https://curecurrent.com/trials/observational-study-on-ger-in-patients-with-simple-obesity-10001https://curecurrent.com/trials/accuracy-and-safety-of-the-syai-tag-system-for-continuous-glucose-monitoring-in-intensive-internal-care-unit-10002https://curecurrent.com/trials/feasibility-and-adoption-of-a-screening-program-for-t1d-relatives-in-canada-10003https://curecurrent.com/trials/sglt2-inhibitor-or-metformin-as-standard-treatment-of-early-stage-type-2-diabetes-10004https://curecurrent.com/trials/assessment-of-diastolic-function-during-the-transitional-period-and-infancy-using-serial-echocardiography-10005https://curecurrent.com/trials/effect-of-dapagliflozin-vs-sitagliptin-on-liver-fat-accumulation-and-body-composition-in-patients-with-diabetes-mellitus-10006https://curecurrent.com/trials/sglt2-inhibition-in-hemodialysis-10007https://curecurrent.com/trials/erectile-function-after-pci-in-mi-and-non-mi-patients-10008https://curecurrent.com/trials/a-study-of-ly3549492-in-chinese-participants-with-type-2-diabetes-mellitus-10009https://curecurrent.com/trials/hong-kong-diabesity-register-3-year-trial-on-integrated-care-for-chinese-with-diabesity-10010https://curecurrent.com/trials/cgm-guided-acarbose-for-painful-diabetic-neuropathy-10011https://curecurrent.com/trials/a-feasibility-study-of-optimal-non-pharmacological-lifestyle-modifications-in-people-with-type-2-diabetes-10012https://curecurrent.com/trials/investigation-of-the-effect-of-intrinsic-foot-muscle-training-on-plantar-pressure-distribution-in-individuals-with-type-10013https://curecurrent.com/trials/clinical-management-of-cardiovascular-risk-factors-in-adult-patients-a-before-and-after-interventional-study-10014https://curecurrent.com/trials/toe-study-treatment-and-gait-analysis-following-an-excised-lesser-toe-10015https://curecurrent.com/trials/glycemic-variability-of-combination-therapies-in-t2dm-10016https://curecurrent.com/trials/investigation-of-pharmacokinetics-and-safety-of-hrs-7535-in-subjects-with-hepatic-impairment-and-normal-hepatic-function-10017https://curecurrent.com/trials/dextenza-vs-prednisolone-acetate-after-cataract-surgery-for-patients-with-diabetes-10018https://curecurrent.com/trials/analysis-of-dr-progression-to-identify-risks-and-need-for-treatment-10019https://curecurrent.com/trials/understanding-acute-dietary-changes-after-glp-1-agonist-treatment-the-glad-feasibility-study-10020https://curecurrent.com/trials/characterisation-of-a-population-of-adults-suffering-from-cystic-fibrosis-in-a-belgian-reference-center-10021https://curecurrent.com/trials/evidence-based-intervention-for-diabetes-prevention-10022https://curecurrent.com/trials/development-and-validation-of-a-risk-prediction-model-for-new-onset-diabetes-after-pancreatectomy-10023https://curecurrent.com/trials/copeptin-concentration-measured-in-plasma-samples-and-intradialytic-blood-pressure-variation-10024https://curecurrent.com/trials/probiotic-on-type-2-diabetes-and-chronic-obstruction-pulmonary-disease-10025https://curecurrent.com/trials/impact-of-laparoscopic-sleeve-gastrectomy-on-obesity-related-comorbidities-in-patients-over-65-years-10026https://curecurrent.com/trials/assessing-the-effects-of-cool-roofs-on-indoor-environments-and-health-10027https://curecurrent.com/trials/the-establishment-of-hong-kong-diabetes-steatotic-liver-disease-register-10028https://curecurrent.com/trials/exploring-reproductive-health-among-women-in-somaliland-10029https://curecurrent.com/trials/assessing-the-effects-of-cool-roofs-on-indoor-environments-and-health-in-niue-10030https://curecurrent.com/trials/investigating-how-cagrisema-semaglutide-and-cagrilintide-regulate-insulin-effects-in-the-body-of-people-with-type-2-diab-10031https://curecurrent.com/trials/mitochondrial-redox-modulation-in-newly-diagnosed-type-2-diabetes-a-randomized-controlled-trial-comparing-imeglimin-vs-m-10032https://curecurrent.com/trials/effects-of-akkermansia-muciniphila-and-berberine-supplementation-on-insulin-sensitivity-in-night-shift-workers-10033https://curecurrent.com/trials/oncometabolic-surgery-10034https://curecurrent.com/trials/efficacy-and-safety-of-henagliflozin-retagliptin-and-metformin-extended-release-tablets-in-chinese-patients-with-type-2-10035https://curecurrent.com/trials/dose-optimization-of-sitagliptin-and-duloxetine-in-diabetic-cirrhosis-10036https://curecurrent.com/trials/continuous-glucose-monitoring-in-dialysis-patients-with-diabetes-10037https://curecurrent.com/trials/topical-insulin-dressing-on-management-of-diabetic-foot-ulcers-10038https://curecurrent.com/trials/early-pregnancy-serum-ferritin-levels-as-a-predictor-for-gestational-diabetes-mellitus-10039https://curecurrent.com/trials/disentangling-the-effect-of-brain-insulin-resistance-on-brain-health-10040https://curecurrent.com/trials/the-effect-of-emotional-freedom-technique-on-patients-receiving-preventive-foot-care-10041https://curecurrent.com/trials/body-composition-fitness-and-thermoregulation-in-young-boys-with-type-i-diabetes-vs-healthy-soccer-players-10042https://curecurrent.com/trials/this-study-is-conducted-to-evaluate-the-18-month-clinical-performance-of-complete-bioactive-restorative-system-for-occlu-10043https://curecurrent.com/trials/serum-endocan-alarin-and-galanin-like-peptide-levels-in-diabetic-retinopathy-10044https://curecurrent.com/trials/dapansutrile-in-diabetes-and-diabetes-related-complications-dapan-dia-10045https://curecurrent.com/trials/a-ph2-study-to-evaluate-the-safety-efficacy-and-tolerability-of-ht-6184-and-semaglutide-in-obese-participants-with-t2dm-10046https://curecurrent.com/trials/evaluation-of-dietary-knowledge-and-the-habit-of-using-the-mediterranean-diet-in-patients-with-diabetes-10047https://curecurrent.com/trials/effect-of-monochromatic-infrared-energy-on-healing-of-diabetic-foot-ulcers-10048https://curecurrent.com/trials/action-of-photodynamic-therapy-on-wound-quality-and-tissue-repair-in-the-diabetic-foot-10049https://curecurrent.com/trials/enhance-evidence-led-co-created-health-systems-interventions-for-mltcs-care-10050https://curecurrent.com/trials/transcutaneous-co-therapy-in-recurrent-hard-to-heal-diabetic-foot-ulcers-10051https://curecurrent.com/trials/immune-system-in-diabetic-kidney-disease-10052https://curecurrent.com/trials/effects-of-vibration-assisted-physical-activity-in-type-2-diabetes-10053https://curecurrent.com/trials/blended-resources-for-integrated-diabetes-guidance-and-empowerment-10054https://curecurrent.com/trials/telemedicine-based-behavioral-intervention-to-improve-outcomes-among-diabetic-patients-10055https://curecurrent.com/trials/tranexamic-acid-vs-vasopressin-in-placenta-previa-trial-10056https://curecurrent.com/trials/closed-loop-for-people-living-with-cystic-fibrosis-related-diabetes-10057https://curecurrent.com/trials/relapse-among-diabetic-ketoacidosis-patients-maintained-basal-bolus-insulin-administration-in-combination-with-continuou-10058https://curecurrent.com/trials/a-pragmatic-randomized-trial-to-evaluate-the-comparative-effectiveness-between-dapagliflozin-and-standard-of-care-in-typ-10059https://curecurrent.com/trials/real-world-canadian-retrospective-study-evaluating-longitudinal-semaglutide-use-on-cardio-kidney-metabolic-outcomes-10060https://curecurrent.com/trials/coolsense-and-buzzy-use-on-pain-score-and-anxiety-level-during-insulin-injection-application-10061https://curecurrent.com/trials/a-multi-centre-trial-to-assess-the-efficacy-and-safety-of-the-omnipod-5-system-in-people-with-type-2-diabetes-undergoing-10062https://curecurrent.com/trials/empagliflozin-and-anakinra-for-the-treatment-of-postprandial-hypoglycemia-in-patients-with-prediabetes-10063https://curecurrent.com/trials/ceramide-containing-multivesicular-emulsion-application-10064https://curecurrent.com/trials/ck-0045-proof-of-concept-study-in-participants-with-overweight-obesity-and-type-2-diabetes-10065https://curecurrent.com/trials/prevention-of-onset-and-transition-to-an-advanced-form-of-diabetic-retinopathy-in-children-10066https://curecurrent.com/trials/the-satiety-control-optimization-by-nutritional-enhancement-study-10067https://curecurrent.com/trials/effect-of-a-nutritional-product-containing-carob-extract-on-carbohydrate-metabolism-in-glucose-intolerant-subjects-10068https://curecurrent.com/trials/mitochondrial-substrate-utilization-in-the-diabetic-human-heart-10069https://curecurrent.com/trials/comparison-of-platelet-rich-plasma-dressing-versus-normal-saline-dressing-for-chronic-non-healing-ulcers-10070https://curecurrent.com/trials/multilevel-ecological-and-com-b-determinants-of-medication-adherence-in-adults-with-diabetes-10071https://curecurrent.com/trials/the-digital-diabetes-patient-reminder-dipar-tool-for-adults-with-type-2-diabetes-10072https://curecurrent.com/trials/va-prevention-randomized-controlled-trial-of-a-person-centred-digital-intervention-to-prevent-diabetes-in-high-risk-adul-10073https://curecurrent.com/trials/intensive-aerobic-and-resistance-exercise-program-iarep-10074https://curecurrent.com/trials/pilot-study-of-intrapartum-insulin-pump-10075https://curecurrent.com/trials/effects-of-fecal-microbiota-transplantation-in-patients-with-type-2-diabetes-and-coronary-artery-disease-cad-microbiome-10076https://curecurrent.com/trials/multicentric-approval-study-trans-duodenal-barrier-for-typ-2-diabetes-with-obesity-10077https://curecurrent.com/trials/cellular-reprogramming-enhanced-skin-grafting-for-diabetic-foot-ulcers-10078https://curecurrent.com/trials/a-study-of-hdm1005-in-participants-with-t2dm-not-controlled-with-metformin-alone-or-in-combination-with-a-sodium-glucose-10079https://curecurrent.com/trials/mumcare-mum-s-cardiovascular-health-for-life-10080https://curecurrent.com/trials/the-trend-of-copeptin-levels-and-its-clinical-value-for-postoperative-cdi-in-pediatric-patients-after-nsi-in-icu-10081https://curecurrent.com/trials/correlation-between-advanced-glycation-end-products-and-gastric-motility-disorder-in-diabetes-gastroparesis-10082https://curecurrent.com/trials/instrumental-assessment-of-plantar-hyperkeratosis-in-healthy-subjects-and-patients-with-diabetes-10083https://curecurrent.com/trials/diabetes-diagnosis-management-prevention-and-education-in-guinea-bissau-10084https://curecurrent.com/trials/ultrarapid-insulin-administered-by-a-bihormonal-closed-loop-system-in-patients-with-type-1-diabetes-10085https://curecurrent.com/trials/switching-to-e-cigarettes-after-type-2-diabetes-diagnosis-and-health-outcomes-10086https://curecurrent.com/trials/self-myofascial-release-plus-exercise-versus-exercise-alone-in-type-2-diabetes-10087https://curecurrent.com/trials/glucose-lowering-drugs-as-an-adjunct-to-insulin-therapy-in-chinese-patients-with-type-1-diabetes-10088https://curecurrent.com/trials/towards-optimal-screening-and-management-of-coronary-artery-disease-in-diabetes-toscana-study-10089https://curecurrent.com/trials/beneficial-effects-of-supplementation-with-cronilief-palmitoylethanolamide-phospholipids-in-diabetic-subjects-with-neuro-10090https://curecurrent.com/trials/effect-of-topical-ozone-on-the-healing-diabetic-foot-ulcer-10091https://curecurrent.com/trials/phoenix-ql1706-plus-chemotherapy-and-bevacizumab-in-aga-resistant-pd-l1-50-non-squamous-nsclc-10092https://curecurrent.com/trials/community-based-chronic-disease-care-in-rural-lesotho-10093https://curecurrent.com/trials/plasma-oxytocin-changes-in-response-to-music-modified-by-sonic-augmentation-technology-10094https://curecurrent.com/trials/treatment-optimization-for-patients-with-type-2-diabetes-using-empagliflozin-and-finerenone-in-a-remote-clinical-trial-10095https://curecurrent.com/trials/efficacy-of-anti-ctla-4-antibody-combined-with-sintilimab-and-chemotherapy-as-neoadjuvant-therapy-for-resectable-stage-i-10096https://curecurrent.com/trials/avoidance-of-insulin-induced-lipohypertophy-in-people-with-diabetes-using-ultrasound-scanning-within-diabetes-clinics-10097https://curecurrent.com/trials/using-lymphovenous-bypass-to-alleviate-diabetic-peripheral-neuropathy-10098https://curecurrent.com/trials/shot-blocker-and-manual-pressure-application-10099https://curecurrent.com/trials/effect-of-vagus-nerve-stimulation-on-pain-intensity-nerve-conduction-studies-and-functional-outcomes-in-diabetic-periphe-10100https://curecurrent.com/trials/evaluation-of-aup12602-c-as-new-topical-treatment-for-dfus-diamend-study-10101https://curecurrent.com/trials/brown-adipose-tissue-metabolism-in-type-2-diabetes-10102https://curecurrent.com/trials/clinical-performance-of-giomer-based-composite-restorations-in-class-v-carious-lesions-in-diabetic-and-non-diabetic-pati-10103https://curecurrent.com/trials/intensive-diet-and-physical-activity-on-diabetes-10104https://curecurrent.com/trials/an-active-health-based-comprehensive-study-on-diabetes-management-10105https://curecurrent.com/trials/a-longitudinal-cohort-study-to-evaluate-cardiovascular-risk-factors-and-disease-in-haiti-10106https://curecurrent.com/trials/effect-of-visualization-of-functional-milk-efficacy-on-perceived-benefits-10107https://curecurrent.com/trials/next-generation-advanced-insulin-delivery-system-in-adults-with-diabetes-and-advanced-renal-disease-10108https://curecurrent.com/trials/ai-assisted-blood-glucose-management-study-10109https://curecurrent.com/trials/idmet-radico-cohort-radico-idmet-10110https://curecurrent.com/trials/closed-loop-impact-on-chronic-kidney-disease-in-type-2-diabetes-10111https://curecurrent.com/trials/impact-of-a-nutritional-intervention-based-on-moroccan-dietary-habits-on-the-glycemic-control-of-type-2-diabetics-10112https://curecurrent.com/trials/efficacy-and-safety-of-sorafenib-in-new-onset-type-1-diabetes-mellitus-10113https://curecurrent.com/trials/establishing-a-virtual-health-community-management-model-for-pre-diabetes-patients-10114https://curecurrent.com/trials/a-prospective-multicenter-clinical-study-intracoronary-near-infrared-spectroscopy-and-optical-coherence-tomography-for-e-10115https://curecurrent.com/trials/effectiveness-of-nutrition-education-in-carbohydrate-counting-in-people-with-type-1-diabetic-10116https://curecurrent.com/trials/a-study-of-bgm0504-in-healthy-participants-and-participants-with-impaired-renal-function-10117https://curecurrent.com/trials/effects-of-semaglutide-on-clinical-outcomes-and-metabolic-inflammation-in-psoriasis-10118https://curecurrent.com/trials/a-research-study-to-understand-how-people-with-type-2-diabetes-take-ozempic-and-if-the-ozempic-app-helps-them-stay-on-th-10119https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-the-insulin-patch-pump-system-in-patients-with-diabetes-10120https://curecurrent.com/trials/new-diagnostic-tool-minion-for-identifying-microorganisms-in-foot-wounds-of-patients-living-with-diabetic-foot-osteomyel-10121https://curecurrent.com/trials/effects-of-ankle-block-on-postoperative-analgesia-in-diabetic-and-non-diabetic-patients-10122https://curecurrent.com/trials/preliminary-assessment-of-an-automated-tool-for-diabetic-retinopathy-screening-10123https://curecurrent.com/trials/time-restricted-eating-for-type-2-diabetes-and-metabolic-health-the-tea-time-trial-10124https://curecurrent.com/trials/to-investigate-impact-of-diet-and-physical-activity-based-nurse-led-interventions-on-maternal-outcomes-and-neonatal-outc-10125https://curecurrent.com/trials/sleeve-gastrectomy-with-transit-bipartition-sg-tb-versus-roux-en-y-gastric-bypass-rygb-for-type-3-obesity-10126https://curecurrent.com/trials/artificial-intelligence-based-early-detection-of-diabetic-retinopathy-fundus-ai-10127https://curecurrent.com/trials/effect-of-a-healthy-food-voucher-on-blood-glucose-control-in-people-with-type-2-diabetes-or-prediabetes-10128https://curecurrent.com/trials/adipose-tissue-storage-in-the-rapid-remission-of-hepatic-and-cardiac-metabolic-dysfunction-after-bariatric-surgery-10129https://curecurrent.com/trials/a-co-created-self-care-and-informal-support-intervention-study-among-women-with-gdm-in-vietnam-10130https://curecurrent.com/trials/investigation-of-the-effect-of-different-activation-techniques-on-tlr9-il6-il10-tnf-alfa-levels-in-healthy-and-type-2-di-10131https://curecurrent.com/trials/study-in-leucocytes-from-patients-with-type-1-and-type-2-diabetes-genetic-markers-of-inflammation-and-oxidative-stress-t-10132https://curecurrent.com/trials/type-2-diabetes-and-binge-eating-disorder-bed-10133https://curecurrent.com/trials/hiit-in-isolated-ifg-a-proof-of-concept-study-10134https://curecurrent.com/trials/impact-of-malnutrition-on-the-healing-of-foot-lesions-in-diabetic-patients-10135https://curecurrent.com/trials/effect-of-victoza-on-dietary-preferences-and-habit-in-patients-with-type-2-diabetes-10136https://curecurrent.com/trials/safety-and-efficacy-of-allogeneic-umbilical-cord-mesenchymal-stem-cell-therapy-in-diabetic-nephropathy-patients-a-clinic-10137https://curecurrent.com/trials/insulin-mediated-glucose-uptake-and-organ-perfusion-assessed-by-total-body-pet-during-gip-and-glp-1-infusion-10138https://curecurrent.com/trials/a-study-of-hdm1005-in-participants-with-type-2-diabetes-not-controlled-with-diet-and-exercise-alone-10139https://curecurrent.com/trials/incidence-of-macular-edema-after-panretinal-photocoagulation-prpc-performed-in-a-single-session-versus-four-sessions-in-10140https://curecurrent.com/trials/search-for-biological-markers-of-orosensory-perception-of-fatty-acids-in-healthy-subjects-and-possible-modifications-in-10141https://curecurrent.com/trials/the-intelligent-diabetes-telemonitoring-using-decision-support-to-treat-patients-on-insulin-therapy-10142https://curecurrent.com/trials/association-between-dry-eye-disease-and-diabetic-macular-edema-10143https://curecurrent.com/trials/complex-all-comers-and-patients-with-diabetes-or-prediabetes-treated-with-xience-sierra-everolimus-eluting-stents-10144https://curecurrent.com/trials/regimen-transition-after-short-term-intensive-insulin-therapy-in-type-2-diabetes-10145https://curecurrent.com/trials/effect-of-liraglutide-on-fatty-liver-content-and-lipoprotein-metabolism-10146https://curecurrent.com/trials/influence-of-glycaemic-balance-on-the-ability-of-apolipoprotein-c1-to-inhibit-cholesteryl-ester-transfer-protein-in-type-10147https://curecurrent.com/trials/reversal-to-normoglycemia-by-treating-prediabetes-10148https://curecurrent.com/trials/investigation-of-the-effectiveness-of-prophylactic-npwt-cinpwt-in-high-risk-diabetic-patients-with-acute-laparotomy-woun-10149https://curecurrent.com/trials/influence-of-bariatric-surgery-on-serum-levels-of-26rfa-10150https://curecurrent.com/trials/the-prospective-double-blind-multicenter-placebo-controlled-randomized-comparative-clinical-trial-10151https://curecurrent.com/trials/multicenter-prospective-observational-study-on-the-treatment-of-type-2-diabetes-with-proline-plus-empagliflozin-tablets-10152https://curecurrent.com/trials/assessment-of-cognitive-function-and-functional-performance-in-patients-with-type-2-diabetes-10153https://curecurrent.com/trials/a-study-of-ct-868-in-overweight-and-obese-participants-with-type-2-diabetes-mellitus-10154https://curecurrent.com/trials/feasibility-of-home-monitoring-of-visual-function-in-dr-10155https://curecurrent.com/trials/screening-for-hypoglycemia-in-an-institutionalized-elderly-diabetic-population-10156https://curecurrent.com/trials/crocus-sativus-tepals-water-extract-in-obesity-and-prediabetes-10157https://curecurrent.com/trials/early-percutaneous-transluminal-angioplasty-in-diabetic-foot-syndrome-pta-dfs-10158https://curecurrent.com/trials/effects-of-glp-1-agonists-on-cardiac-steatosis-evaluated-by-magnetic-resonance-imaging-10159https://curecurrent.com/trials/glucagon-resistance-in-patients-with-masld-and-t2dm-10160https://curecurrent.com/trials/disaster-preparedness-in-patients-with-diabetic-foot-the-effect-of-an-educational-intervention-10161https://curecurrent.com/trials/omega-3-pufa-and-aspirin-as-adjunctive-therapy-in-treatment-of-smoker-patients-with-stage-iii-periodontitis-10162https://curecurrent.com/trials/montreal-immune-related-adverse-events-mirae-study-10163https://curecurrent.com/trials/efficacy-and-safety-of-livalozet-in-hypercholesterolemic-patients-with-and-without-diabetes-10164https://curecurrent.com/trials/feasibility-of-simulation-in-therapeutic-patient-education-for-adult-diabetic-patients-using-the-freestyle-libre-device-10165https://curecurrent.com/trials/study-of-the-psychological-profile-of-type-2-diabetic-patients-with-foot-wounds-compared-to-diabetic-patients-without-fo-10166https://curecurrent.com/trials/ramadan-experience-of-individuals-with-type-2-diabetes-10167https://curecurrent.com/trials/effects-of-education-and-telephone-support-on-type-2-diabetes-management-10168https://curecurrent.com/trials/a-study-between-dapagliflozin-and-empagliflozin-effect-on-nafld-in-patients-with-type-2-diabetes-10169https://curecurrent.com/trials/study-on-glycemic-variations-in-diabetic-patients-treated-with-chemotherapy-benefit-of-continuous-interstitial-glucose-m-10170https://curecurrent.com/trials/the-micron-study-a-steno-1-substudy-10171https://curecurrent.com/trials/clinical-effect-of-swedish-massage-versus-adjuvant-yoga-on-blood-glucose-level-in-children-with-type-1-diabetes-mellitus-10172https://curecurrent.com/trials/petit-cactus-study-10173https://curecurrent.com/trials/cardio-reno-hepato-metabolic-disease-in-chronic-heart-failure-carmen-chf-10174https://curecurrent.com/trials/evaluating-a-liquid-extract-of-carob-to-improve-blood-sugar-in-people-with-prediabetes-10175https://curecurrent.com/trials/coronary-artery-risk-development-in-young-adults-10176https://curecurrent.com/trials/effects-of-vitamin-d3-and-yeast-beta-glucan-supplementation-on-glycemic-control-and-cardiovascular-disease-risk-in-patie-10177https://curecurrent.com/trials/norepinephrine-and-vasopressin-for-rescue-versus-early-vasopressin-for-vasopressor-dependent-sepsis-10178https://curecurrent.com/trials/insulin-use-and-respiratory-muscle-strength-in-type-2-diabetes-10179https://curecurrent.com/trials/hemoglobin-levels-and-resolution-time-of-diabetic-ketoacidosis-in-pediatric-patients-10180https://curecurrent.com/trials/cobas-lumira-collection-of-venous-and-capillary-blood-samples-for-the-research-optimization-and-calibration-of-new-diagn-10181https://curecurrent.com/trials/efficacy-and-safety-of-cold-atmospheric-plasma-combined-with-endovascular-intervention-in-patients-with-diabetic-foot-ul-10182https://curecurrent.com/trials/effects-of-selected-statins-on-blood-glucose-levels-in-healthy-volunteers-10183https://curecurrent.com/trials/time-in-range-vs-time-in-normal-glycemia-for-better-glycemic-control-10184https://curecurrent.com/trials/effects-of-lp-ldl-on-lipid-metabolism-glycemic-control-inflammatory-markers-and-cognitive-function-in-individuals-with-p-10185https://curecurrent.com/trials/the-impact-of-changing-to-a-new-child-and-family-centered-outpatient-diabetes-clinic-focusing-on-early-involvement-of-th-10186https://curecurrent.com/trials/the-role-of-inflammatory-biomarkers-in-preventing-deep-sternal-wound-infections-after-sternotomy-10187https://curecurrent.com/trials/effect-of-interactive-video-based-self-management-education-in-adults-with-type-2-diabetes-10188https://curecurrent.com/trials/carotid-wall-texture-as-a-cardiovascular-risk-biomarker-in-type-2-diabetes-mellitus-10189https://curecurrent.com/trials/research-study-of-how-well-semaglutide-works-in-people-living-with-overweight-or-obesity-10190https://curecurrent.com/trials/nuclear-abnormalities-in-gingival-epithelial-cells-in-relation-to-periodontal-disease-10191https://curecurrent.com/trials/effects-of-sweetener-consumption-on-risk-factors-for-heart-disease-in-prediabetic-subjects-10192https://curecurrent.com/trials/effect-of-partial-dietary-replacement-from-animal-to-plant-based-protein-for-type-2-diabetes-management-10193https://curecurrent.com/trials/cardio-metabolic-diseases-in-immigrants-and-ethnic-minorities-from-epidemiology-to-new-prevention-strategies-10194https://curecurrent.com/trials/strategies-to-minimize-the-risk-for-insulin-induced-hypertrophy-and-its-related-consequences-10195https://curecurrent.com/trials/vinegar-vs-normal-saline-dressing-for-diabetic-foot-ulcers-10196https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-in-prediabetes-10197https://curecurrent.com/trials/maximising-time-with-a-normal-blood-glucose-to-restore-the-glucagon-response-in-type-1-diabetes-10198https://curecurrent.com/trials/metabolic-deterioration-in-htx-determines-outcomes-10199https://curecurrent.com/trials/risk-factors-for-developing-peak-plantar-pressure-during-walking-in-the-diabetic-patients-10200https://curecurrent.com/trials/type-2-diabetes-with-nafld-innovative-biomarkers-of-disease-progression-and-clinical-outcomes-10201https://curecurrent.com/trials/nutritional-management-of-the-patient-with-type-2-diabetes-at-nutritional-risk-or-with-malnutrition-in-clinical-practice-10202https://curecurrent.com/trials/triple-hypoglycemic-regimens-in-patients-with-newly-diagnosed-type-2-diabetes-mellitus-10203https://curecurrent.com/trials/bioequivalence-study-to-compare-empagliflozin-metformin-25-mg-1000-mg-extended-release-tablet-versus-synjardy-xr-tablets-10204https://curecurrent.com/trials/gummy-candies-with-maqui-berry-10205https://curecurrent.com/trials/improving-cardiovascular-disease-diagnosis-and-treatment-in-kazakhstan-using-metabolic-correction-with-glp-1-drugs-10206https://curecurrent.com/trials/psychological-well-being-depression-and-health-related-quality-of-life-in-adults-with-type-2-diabetes-a-cross-sectional-10207https://curecurrent.com/trials/effect-of-acupressure-on-blood-glucose-and-anxiety-in-elderly-with-diabetes-10208https://curecurrent.com/trials/association-of-preoperative-hippocampal-glucose-metabolism-with-postoperative-delirium-in-older-diabetic-patients-10209https://curecurrent.com/trials/oeod-based-wound-dressing-in-post-surgical-diabetic-foot-ulcers-10210https://curecurrent.com/trials/a-study-comparing-hr17031-with-insulin-glargine-in-patients-with-type-2-diabetes-10211https://curecurrent.com/trials/melatonin-for-glycemic-control-in-gestational-diabetes-mellitus-10212https://curecurrent.com/trials/glucagon-like-peptide-1-receptor-agonist-in-diabetes-mellitus-management-in-children-and-adolescents-with-transfusion-de-10213https://curecurrent.com/trials/high-intensity-interval-exercise-compared-with-continuous-moderate-exercise-on-glycemia-in-postabsorptive-vs-postprandia-10214https://curecurrent.com/trials/is-there-a-benefit-from-addition-of-exercise-in-diabetic-patients-with-ed-who-complain-low-vitamin-d-10215https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-empagliflozin-or-glimepiride-combination-therapy-in-type-2-diabetes-mellitus-patient-10216https://curecurrent.com/trials/effect-of-sodium-glucose-co-transporter-2-sglt-2-inhibitors-on-body-mass-index-after-3-months-of-use-in-diabetic-patient-10217https://curecurrent.com/trials/cmate-blood-glucose-analyzer-clinical-comparison-study-of-fasting-blood-glucose-levels-in-the-morning-10218https://curecurrent.com/trials/study-of-roxadustat-s-effect-on-anemia-in-patients-with-diabetic-kidney-disease-10219https://curecurrent.com/trials/gip-glp-1ra-as-adjunctive-to-automated-insulin-delivery-in-adults-with-type-1-diabetes-10220https://curecurrent.com/trials/early-sleeve-gastrectomy-in-new-onset-diabetic-obese-patients-10221https://curecurrent.com/trials/feasibility-of-aerobic-exercise-with-blood-flow-restriction-training-in-people-living-with-type-2-diabetes-10222https://curecurrent.com/trials/diabetic-foot-ulcer-research-study-10223https://curecurrent.com/trials/real-life-follow-up-of-the-physical-activity-in-type-1-diabetes-participants-equipped-with-an-insulin-pump-with-hybrid-c-10224https://curecurrent.com/trials/transition-to-hospital-discharge-in-insulinized-patients-with-type-2-diabetes-mellitus-10225https://curecurrent.com/trials/multimodal-cardiovascular-magnetic-resonance-imaging-for-cardiometabolic-pre-hf-and-hfpef-10226https://curecurrent.com/trials/evaluating-an-analogy-based-consultation-approach-for-insulin-treated-type-2-diabetes-patients-10227https://curecurrent.com/trials/platelet-changes-in-type-2-diabetes-10228https://curecurrent.com/trials/paraclinical-cardiometabolic-risk-assessment-in-type-2-diabetes-10229https://curecurrent.com/trials/study-on-adherence-to-a-mediterranean-diet-in-a-population-of-patients-with-type-2-diabetes-10230https://curecurrent.com/trials/diamester-pilot-rct-e-health-lifestyle-program-for-type-2-diabetes-10231https://curecurrent.com/trials/omt-28-in-patients-with-primary-mitochondrial-disease-pmd-pmd-option-10232https://curecurrent.com/trials/safety-and-feasibility-of-a-novel-endoscopic-intervention-for-the-treatment-of-type-ii-diabetes-10233https://curecurrent.com/trials/urinary-function-and-multimorbidity-risks-a-longitudinal-study-in-beijing-community-dwelling-elderly-10234https://curecurrent.com/trials/systemic-organ-communication-in-stemi-10235https://curecurrent.com/trials/octa-in-cardiovascular-disease-and-healthy-controls-10236https://curecurrent.com/trials/smartadjust-2-0-system-with-type-1-and-type-2-diabetes-10237https://curecurrent.com/trials/real-world-safety-efficacy-experience-of-empagliflozin-with-or-without-metformin-in-t2dm-patients-ease-study-10238https://curecurrent.com/trials/assessment-of-carbohydrate-counting-accuracy-and-glycemic-control-among-sohag-university-students-with-type-1-diabetes-10239https://curecurrent.com/trials/multi-ethnic-study-of-atherosclerosis-mesa-10240https://curecurrent.com/trials/dual-hormone-closed-loop-in-type-1-diabetes-10241https://curecurrent.com/trials/the-effect-of-a-web-based-education-program-on-eating-habits-metabolic-control-and-self-management-in-adolescents-with-t-10242https://curecurrent.com/trials/periodontitis-and-inflammation-10243https://curecurrent.com/trials/community-empowerment-and-environmental-enrichment-based-co-management-ceeec-model-and-mechanisms-for-improving-health-o-10244https://curecurrent.com/trials/multifactorial-strategies-for-the-prevention-of-the-risks-of-ulceration-in-patients-affected-by-diabetic-foot-dare-diafo-10245https://curecurrent.com/trials/system-accuracy-and-performance-evaluation-by-the-user-of-bgm-ls-9-10246https://curecurrent.com/trials/effect-of-omega-3-supplementation-as-add-on-therapy-on-glycemic-control-and-lipid-profile-in-type2-diabetes-mellitus-10247https://curecurrent.com/trials/short-term-glycemic-control-for-reducing-post-surgical-complications-10248https://curecurrent.com/trials/pilot-resistance-exercise-for-inpatient-treatment-in-t2d-10249https://curecurrent.com/trials/impact-of-diabetes-related-metabolic-derangements-on-clinical-outcomes-in-hospitalized-patients-with-chronic-kidney-dise-10250https://curecurrent.com/trials/short-term-effects-of-carbohydrate-restricted-diet-on-glycemic-and-metabolic-control-among-children-and-adolescent-with-10251https://curecurrent.com/trials/diabetes-screening-in-patients-on-long-term-glucocorticoid-therapy-10252https://curecurrent.com/trials/study-on-the-intervention-effect-of-denosumab-on-high-risk-patients-with-osteoporotic-fractures-in-type-2-diabetes-10253https://curecurrent.com/trials/engagement-of-community-through-participatory-learning-and-action-for-control-and-prevention-of-type-ii-diabetes-and-its-10254https://curecurrent.com/trials/gut-microbiota-and-serum-metabolites-as-predictors-of-glycemic-variability-and-outcomes-in-diabetic-kidney-disease-10255https://curecurrent.com/trials/impact-of-the-new-generation-anti-diabetic-drugs-on-diabetic-retinopathy-10256https://curecurrent.com/trials/targeted-precision-nutrition-strategy-to-prevent-chronic-metabolic-diseases-10257https://curecurrent.com/trials/the-project-for-managing-cardiometabolic-risk-in-women-diagnosed-with-gestational-diabetes-mellitus-10258https://curecurrent.com/trials/magnetic-compression-anastomosis-procedure-for-partial-jejuno-ileal-diversion-evaluating-the-feasibility-of-a-novel-endo-10259https://curecurrent.com/trials/the-fenofibrate-and-microvascular-events-in-type-1-diabetes-eye-10260https://curecurrent.com/trials/identification-and-clinical-relevance-of-an-oxytocin-deficient-state-glp1-study-10261https://curecurrent.com/trials/sleep-hygiene-education-in-type-2-diabetes-10262https://curecurrent.com/trials/the-diabeat-study-insulin-delivery-technologies-and-eating-behaviours-in-people-with-type-1-diabetes-10263https://curecurrent.com/trials/a-study-of-zt002-in-healthy-participants-10264https://curecurrent.com/trials/understanding-beta-cell-disorders-through-the-study-of-rare-genotypes-endure-10265https://curecurrent.com/trials/residual-gastric-content-after-holding-of-glucagon-like-peptide-1-receptor-agonists-before-elective-surgery-10266https://curecurrent.com/trials/a-study-using-breath-tests-to-identify-patients-at-risk-for-gestational-diabetes-10267https://curecurrent.com/trials/does-screening-of-coronary-artery-disease-an-efficient-public-health-strategy-in-patients-with-type-2-diabetes-10268https://curecurrent.com/trials/artificial-intelligence-and-gestacional-diabetes-10269https://curecurrent.com/trials/diabetes-islet-preservation-immune-treatment-10270https://curecurrent.com/trials/prognostic-determinants-in-patients-with-diabetic-foot-ulcer-10271https://curecurrent.com/trials/additional-effects-of-sensory-integration-along-with-focused-regimen-exercises-on-kinaesthesia-proprioception-in-diabeti-10272https://curecurrent.com/trials/new-markers-of-glycation-to-predict-gestational-diabetes-mellitus-and-macrosomia-10273https://curecurrent.com/trials/study-of-oral-uremic-toxin-absorbent-probiotics-to-modulate-systemic-inflammation-and-retard-the-progression-of-chronic-10274https://curecurrent.com/trials/endocare-screen-metabolic-liver-dysfunction-screening-study-10275https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-cmg190303-in-patients-with-type-2-diabetes-and-dyslipidemia-10276https://curecurrent.com/trials/assessment-of-antithyroglobulin-antibody-levels-among-diabetic-patients-10277https://curecurrent.com/trials/intelligent-evaluation-of-diabetic-retinopathy-10278https://curecurrent.com/trials/assay-for-the-pancreatic-polypeptide-an-help-for-clinical-practice-guidelines-in-classification-of-the-diabetes-10279https://curecurrent.com/trials/comparison-between-two-durations-of-antibiotherapy-for-non-surgically-treated-diabetic-foot-osteomyelitis-chronos-2-10280https://curecurrent.com/trials/to-evaluate-the-change-in-glucose-parameters-in-adult-patients-with-type-1-or-type-2-diabetes-from-europe-using-the-ican-10281https://curecurrent.com/trials/effects-of-marching-exercise-with-cognitive-training-on-physical-cognitive-function-and-autonomic-cardiovascular-respons-10282https://curecurrent.com/trials/exercising-in-hot-conditions-how-does-it-effect-blood-glucose-in-people-with-t1d-10283https://curecurrent.com/trials/targeted-assessment-in-high-risk-patients-with-diabetes-to-identify-undiagnosed-heart-failure-10284https://curecurrent.com/trials/implementation-and-evaluation-of-a-pharmacist-led-diabetes-care-pathway-in-alberta-community-pharmacies-10285https://curecurrent.com/trials/effectiveness-of-a-virtual-health-management-community-vhmc-for-pre-diabetes-in-china-10286https://curecurrent.com/trials/preventing-diabetes-impact-of-an-emr-based-intervention-for-enhanced-pre-diabetes-management-in-primary-care-10287https://curecurrent.com/trials/lung-cancer-risk-in-type-2-diabetes-with-copd-sglt2-inhibitors-vs-sulfonylureas-10288https://curecurrent.com/trials/effect-of-tvns-in-obesity-10289https://curecurrent.com/trials/a-trial-comparing-hr17031-with-insulin-glargine-in-patients-with-type-2-diabetes-10290https://curecurrent.com/trials/fetus-programming-and-long-active-outcomes-interaction-between-mother-placenta-and-fetus-in-perinatal-and-methabolic-dis-10291https://curecurrent.com/trials/study-of-the-performance-of-the-glucube-system-in-patients-with-type-2-diabetes-10292https://curecurrent.com/trials/residual-kidney-function-and-oxidative-stress-in-incremental-vs-standard-peritoneal-dialysis-2-mexican-centers-10293https://curecurrent.com/trials/does-recessive-optic-atrophy-due-to-wfs1-exist-10294https://curecurrent.com/trials/evaluation-and-treatment-for-diabetic-peripheral-neuropathy-10295https://curecurrent.com/trials/continuous-glucose-monitoring-in-non-insulin-treated-type-2-diabetes-continuous-vs-periodic-use-10296https://curecurrent.com/trials/spiritual-care-for-psychological-and-glycemic-outcomes-in-type-2-diabetes-10297https://curecurrent.com/trials/effects-of-yoghurt-consumption-on-glucose-metabolism-in-prediabetic-subjects-10298https://curecurrent.com/trials/evaluation-of-the-effect-of-type-2-diabetes-mellitus-on-the-success-of-adult-pulpotomy-10299https://curecurrent.com/trials/impact-of-an-educational-intervention-on-ulcer-incidence-knowledge-self-care-and-quality-of-life-in-diabetic-foot-syndro-10300https://curecurrent.com/trials/targeting-neurovascular-coupling-in-cognitive-decline-via-nitrate-based-supplementation-10301https://curecurrent.com/trials/a-research-study-in-saudi-arabia-to-understand-how-the-dose-check-app-used-with-tresiba-treatment-helps-to-control-blood-10302https://curecurrent.com/trials/quinoa-improves-glycolipid-metabolism-and-glucose-fluctuation-based-on-cell-function-in-early-stage-type-2-diabetes-10303https://curecurrent.com/trials/prevalence-of-post-traumatic-stress-disorder-related-to-diabetes-diagnosis-or-severe-hypoglycaemia-in-adult-with-type-1-10304https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-tolerability-of-te-8105-in-overweight-obese-participants-without-diabetes-10305https://curecurrent.com/trials/probiotic-effects-in-type-2-diabetes-10306https://curecurrent.com/trials/crystalsight-cohort-1-5-clinical-investigation-study-with-occutrack-and-tan-tock-seng-eye-clinic-to-further-develop-remo-10307https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-for-ta-7284-in-patients-with-type-2-diabetes-10308https://curecurrent.com/trials/restoration-of-hypoglycemia-awareness-with-home-based-high-intensity-interval-training-10309https://curecurrent.com/trials/aquacel-ag-extra-vs-cutimed-sorbact-10310https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-ta-7284-in-type-2-diabetic-patients-10311https://curecurrent.com/trials/finerenone-for-cardiorenal-protection-in-diabetic-ckd-impact-on-renal-function-decline-and-heart-failure-10312https://curecurrent.com/trials/long-term-safety-study-of-canagliflozin-ta-7284-in-combination-with-insulin-in-patients-with-type-2-diabetes-mellitus-10313https://curecurrent.com/trials/efficacy-and-safety-study-of-ta-7284-in-patients-with-type-2-diabetes-10314https://curecurrent.com/trials/a-study-to-evaluate-the-pk-pd-and-safety-of-ta-7284-in-patients-with-type-2-diabetes-mellitus-who-have-moderate-renal-im-10315https://curecurrent.com/trials/serum-chromium-nickel-and-magnesium-in-type-2-diabetic-periodontitis-10316https://curecurrent.com/trials/electronic-real-time-heart-team-decision-making-vs-usual-care-in-patients-with-triple-vessel-coronary-artery-disease-and-10317https://curecurrent.com/trials/impact-of-diet-and-exercise-activity-on-pregnancy-outcomes-10318https://curecurrent.com/trials/long-term-safety-study-of-ta-7284-in-patients-with-type-2-diabetes-mellitus-10319https://curecurrent.com/trials/long-term-safety-study-of-canagliflozin-ta-7284-in-combination-with-glp-1-analogue-in-patients-with-type-2-diabetes-mell-10320https://curecurrent.com/trials/efficacy-and-safety-study-of-canagliflozin-ta-7284-in-combination-with-insulin-in-patients-with-type-2-diabetes-mellitus-10321https://curecurrent.com/trials/automated-insulin-delivery-in-adults-with-advanced-kidney-disease-10322https://curecurrent.com/trials/pharmacist-case-finding-and-intervention-for-vascular-prevention-trial-10323https://curecurrent.com/trials/efficacy-and-safety-of-mp-513-in-combination-with-metformin-in-patients-with-type-2-diabetes-10324https://curecurrent.com/trials/comparison-of-low-intensity-statin-plus-ezetimibe-versus-high-intensity-statin-therapy-on-risk-of-new-onset-diabetes-mel-10325https://curecurrent.com/trials/confirmatory-study-of-mt-2412-in-japanese-patients-with-type-2-diabetes-add-on-study-of-canagliflozin-10326https://curecurrent.com/trials/long-term-safety-study-of-mt-2412-in-japanese-patients-with-type-2-diabetes-10327https://curecurrent.com/trials/efficacy-and-safety-of-canagliflozin-ta-7284-in-patients-with-diabetic-nephropathy-10328https://curecurrent.com/trials/improving-oral-health-knowledge-and-habits-in-people-with-diabetes-through-a-theory-guided-whatsapp-education-program-10329https://curecurrent.com/trials/brain-clock-and-insulin-resistance-10330https://curecurrent.com/trials/outcomes-based-health-program-for-type-2-diabetes-10331https://curecurrent.com/trials/confirmatory-study-of-mt-2412-in-japanese-patients-with-type-2-diabetes-add-on-study-of-teneligliptin-10332https://curecurrent.com/trials/effects-of-henagliflozin-proline-and-metformin-xr-on-body-composition-in-geriatric-patients-with-newly-diagnosed-t2dm-10333https://curecurrent.com/trials/grape-gdm-prospective-comperative-trial-grape-juice-as-a-replacement-drink-for-gestational-diabetes-screening-10334https://curecurrent.com/trials/efficacy-and-safety-of-teneligliptin-in-combination-with-metformin-in-chinese-patients-with-type-2-diabetes-mellitus-10335https://curecurrent.com/trials/evaluation-of-a-mobile-ai-powered-decision-support-system-for-insulin-dosing-and-glucose-prediction-in-type-1-diabetes-t-10336https://curecurrent.com/trials/efficacy-and-safety-study-of-mci-196-in-patients-with-type-2-diabetes-10337https://curecurrent.com/trials/comparison-of-different-doses-of-vitamin-d-supplementation-on-glycated-haemoglobin-and-blood-glucose-parameters-with-typ-10338https://curecurrent.com/trials/effect-of-green-tea-on-obese-pediatrics-with-prediabetes-10339https://curecurrent.com/trials/effectiveness-of-mobile-application-supported-education-and-counseling-in-pregnant-women-with-gestational-diabetes-10340https://curecurrent.com/trials/efficacy-and-safety-of-the-apgo-algorithm-for-automated-insulin-delivery-10341https://curecurrent.com/trials/efficacy-and-safety-of-teneligliptin-in-chinese-patients-with-type-2-diabetes-mellitus-10342https://curecurrent.com/trials/the-seafarers-continuous-glucose-monitoring-systems-study-10343https://curecurrent.com/trials/clinical-trial-investigating-the-effect-of-exosomes-as-a-complementary-treatment-in-severe-to-moderate-erectile-dysfunct-10344https://curecurrent.com/trials/efficacy-and-safety-of-hrs-7535-tablets-in-adults-with-diabetic-kidney-disease-in-type-2-diabetes-10345https://curecurrent.com/trials/efficacy-and-safety-study-of-mp-513-in-combination-with-sulfonylurea-in-patients-with-type-2-diabetes-10346https://curecurrent.com/trials/a-study-about-patient-decision-aids-designed-to-help-parents-and-guardians-in-canada-make-evidence-informed-values-congr-10347https://curecurrent.com/trials/in-shoe-pressures-associated-with-footwear-fit-guidelines-10348https://curecurrent.com/trials/long-term-safety-study-of-mp-513-as-monotherapy-or-in-combination-with-sulfonylurea-in-japanese-type-2-diabetic-patients-10349https://curecurrent.com/trials/efficacy-and-safety-study-of-mp-513-in-combination-with-thiazolidinedione-in-patients-with-type-2-diabetes-10350https://curecurrent.com/trials/multicenter-study-on-cardiovascular-and-metabolic-complications-in-patients-with-biochemically-silent-pheochromocytomas-10351https://curecurrent.com/trials/the-force-frequency-relationship-in-heart-failure-and-diabetes-mellitus-a-metabolic-aetiology-10352https://curecurrent.com/trials/effects-of-dapagliflozin-on-inflammatory-factorslevel-and-prognosis-in-type-2-diabetes-with-acute-myocardial-infarction-10353https://curecurrent.com/trials/communit1d-a-customized-virtual-peer-support-program-for-people-living-with-type-1-diabetes-in-canada-10354https://curecurrent.com/trials/remote-support-for-low-carbohydrate-treatment-of-type-2-diabetes-10355https://curecurrent.com/trials/central-sensitization-in-painful-and-painless-diabetic-peripheral-neuropathy-10356https://curecurrent.com/trials/the-effects-of-upper-extremity-aerobic-exercise-training-in-patients-with-type-2-diabetes-10357https://curecurrent.com/trials/efficacy-and-safety-of-hrs9531-in-participants-with-type-2-diabetes-treated-with-basal-insulin-10358https://curecurrent.com/trials/prenatal-exercise-including-perineal-massage-and-maternal-neonatal-outcomes-10359https://curecurrent.com/trials/monotherapy-study-of-mp-513-in-patients-with-type-2-diabetes-10360https://curecurrent.com/trials/efficacy-and-safety-study-of-teneligliptin-mp-513-in-combination-with-insulin-in-patients-with-type-2-diabetes-10361https://curecurrent.com/trials/effectiveness-of-individualized-automatic-coaching-message-for-glycemic-management-and-depressive-symptom-10362https://curecurrent.com/trials/glp1-ras-effects-on-inflammatory-and-endothelial-biomarkers-in-t2dm-10363https://curecurrent.com/trials/the-effects-of-calisthenic-exercise-training-in-patients-with-type-2-diabetes-10364https://curecurrent.com/trials/long-term-safety-study-of-mp-513-in-patients-with-type-2-diabetes-10365https://curecurrent.com/trials/2025-hypoglycemia-early-warning-and-physician-nurse-collaborative-management-trial-in-type-2-diabetes-10366https://curecurrent.com/trials/maternal-sleep-and-lifestyle-metabolic-health-and-perinatal-outcomes-in-gestational-diabetes-10367https://curecurrent.com/trials/weaning-approaches-for-vasopressin-in-sepsis-10368https://curecurrent.com/trials/efficacy-and-safety-study-of-mp-513-in-patients-with-type-2-diabetes-10369https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-study-of-mp-513-with-type-2-diabetes-mellitus-10370https://curecurrent.com/trials/a-research-study-of-a-new-medicine-nnc0519-0130-in-healthy-people-people-with-high-body-weight-and-people-with-type-2-di-10371https://curecurrent.com/trials/goal-a-research-study-looking-at-long-term-blood-sugar-control-in-people-with-type-2-diabetes-treated-with-xultophy-in-l-10372https://curecurrent.com/trials/thymoquinone-as-an-add-on-therapy-for-the-management-of-patients-with-diabetic-peripheral-neuropathy-10373https://curecurrent.com/trials/regulatory-post-marketing-surveillance-rpms-study-of-xultophy-insulin-degludec-liraglutide-to-evaluate-safety-and-effect-10374https://curecurrent.com/trials/a-research-study-looking-at-how-the-use-of-novopen-6-for-treatment-with-tresiba-fiasp-affects-the-blood-sugar-level-in-p-10375https://curecurrent.com/trials/a-comparison-of-effectiveness-safety-and-cost-effectiveness-of-dapagliflozin-and-empagliflozin-in-patients-with-type-2-d-10376https://curecurrent.com/trials/effect-of-supervised-in-comparison-to-non-supervised-multicomponent-exercise-training-on-balance-and-quality-of-life-in-10377https://curecurrent.com/trials/effect-of-narrative-education-on-glycemic-control-in-adults-with-type-2-diabetes-in-primary-care-10378https://curecurrent.com/trials/a-research-study-of-how-safe-a-new-medicine-called-nnc0519-0130-is-and-to-test-its-effect-in-people-living-with-excess-b-10379https://curecurrent.com/trials/evaluation-of-glycemic-impact-on-fetal-liver-length-and-volume-by-ultrasound-in-pregnancy-10380https://curecurrent.com/trials/effects-of-berberine-on-preventing-cardiovascular-disease-and-diabetes-mellitus-10381https://curecurrent.com/trials/raman-spectroscopy-based-non-invasive-blood-glucose-detection-10382https://curecurrent.com/trials/a-research-study-of-a-new-medicine-nnc0113-6856-in-healthy-males-10383https://curecurrent.com/trials/masld-in-type-2-diabetes-in-primary-care-a-follow-up-study-10384https://curecurrent.com/trials/mechanisms-of-fecal-incontinence-in-wolfram-syndrome-10385https://curecurrent.com/trials/clinical-morphometric-and-biochemical-effects-on-adiposopathy-associated-with-the-use-of-glp-1ra-in-ckd-10386https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-compared-with-intermittent-continuous-glucose-monitoring-in-people-with-type-2-d-10387https://curecurrent.com/trials/gestational-diabetes-and-human-milk-composition-study-10388https://curecurrent.com/trials/real-world-effectiveness-of-oral-semaglutide-in-thailand-participants-with-type-2-diabetes-10389https://curecurrent.com/trials/mediterranean-diet-vs-dash-and-mind-in-t2dm-10390https://curecurrent.com/trials/association-between-cgm-metrics-in-type-2-diabetes-pregnancy-and-perinatal-morbidity-10391https://curecurrent.com/trials/wide-field-octa-in-ocular-diseases-10392https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-finland-as-part-of-local-clinic-10393https://curecurrent.com/trials/myo-inositol-for-reduction-of-insulin-therapy-in-gestational-diabetes-mellitus-10394https://curecurrent.com/trials/neurophysiological-autonomic-and-sonographic-assessment-of-diabetic-peripheral-neuropathy-10395https://curecurrent.com/trials/prevalence-of-obstructive-sleep-apnea-syndrome-in-type-1-diabetic-patients-treated-with-insulin-pump-at1home-10396https://curecurrent.com/trials/precision-diabetes-management-integrated-east-west-approach-10397https://curecurrent.com/trials/nutritional-rehabilitation-and-sleep-apnea-in-the-obese-10398https://curecurrent.com/trials/generative-ai-based-simulation-for-diagnostic-communication-in-type-2-diabetes-dialogue-dm2-10399https://curecurrent.com/trials/diagnosing-gdm-using-oral-sugar-instead-10400https://curecurrent.com/trials/individualized-early-diagnosis-and-treatment-system-of-gestational-diabetes-mellitus-gdm-based-on-new-continuous-glucose-10401https://curecurrent.com/trials/prediction-model-for-the-risk-of-developing-foot-ulcers-in-diabetes-10402https://curecurrent.com/trials/semaglutide-treatment-for-hyperglycaemia-after-renal-transplantation-10403https://curecurrent.com/trials/bridge-study-to-evaluate-the-efficacy-and-safety-of-in-b00009-injection-in-patients-with-t2dm-inadequately-controlled-by-10404https://curecurrent.com/trials/magnetic-duodeno-ileal-chile-study-10405https://curecurrent.com/trials/effects-of-calcium-on-gut-functions-and-blood-glucose-in-humans-with-type-2-diabetes-10406https://curecurrent.com/trials/efficacy-of-extracorporeal-photopheresis-ecp-in-the-treatment-of-type-1-diabetes-mellitus-10407https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-ckd-383-0-25-12-5-1000mg-in-healthy-volunteers-10408https://curecurrent.com/trials/effect-of-a-low-advanced-glycation-end-products-diet-of-patients-with-type-2-diabetes-mellitus-10409https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-ckd-383-0-5-10-1000mg-in-healthy-volunteers-10410https://curecurrent.com/trials/family-focused-community-program-to-prevent-type-2-diabetes-in-peripubertal-youth-10411https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-ckd-383-0-5-25-1000mg-in-healthy-volunteers-10412https://curecurrent.com/trials/prevention-of-renal-failure-in-people-followed-for-type-2-diabetes-in-general-practice-10413https://curecurrent.com/trials/combination-of-bitter-melon-extract-and-snakehead-fish-powder-to-reduce-glycaemia-in-type-2-diabetes-mellitus-10414https://curecurrent.com/trials/sodium-glucose-co-transporter-2-inhibitors-on-estimated-glomerular-filtration-rate-in-diabetic-versus-non-diabetic-chron-10415https://curecurrent.com/trials/metformin-and-molecular-aging-in-prediabetes-10416https://curecurrent.com/trials/impact-of-sorghum-rice-on-beta-cell-function-and-insulin-resistance-in-prediabetes-10417https://curecurrent.com/trials/tvns-motivation-and-insulin-sensitivity-10418https://curecurrent.com/trials/efficacy-of-diacylglycerol-oil-on-metabolic-risk-factors-in-prediabetes-10419https://curecurrent.com/trials/efficacy-of-whole-body-electromyostimulation-wb-ems-training-in-participants-with-pre-diabetes-10420https://curecurrent.com/trials/combined-bitter-melon-extract-and-snakehead-fish-powder-supplementation-for-glycemic-control-in-type-2-diabetes-10421https://curecurrent.com/trials/finndiane-lifeone-study-impact-of-ageing-on-people-with-type-1-diabetes-10422https://curecurrent.com/trials/comparing-single-versus-multiple-anti-vegf-injections-in-diabetic-patients-undergoing-cataract-surgery-10423https://curecurrent.com/trials/mesenchymal-stem-cells-for-chronic-kidney-diseases-10424https://curecurrent.com/trials/randomised-trial-of-dual-device-treatment-involving-drug-coated-balloon-angioplasty-and-drug-eluting-stent-implantation-10425https://curecurrent.com/trials/insulin-and-abatacept-in-recently-diagnosed-type-1-diabetes-10426https://curecurrent.com/trials/diabetic-nephropathy-in-people-with-diabetes-prevalence-and-predictive-factors-10427https://curecurrent.com/trials/characterization-of-placental-diffusion-10428https://curecurrent.com/trials/the-cgm-ogtt-glycemic-homeostasis-study-10429https://curecurrent.com/trials/magnetic-jejuno-ileal-diversion-study-mji-study-10430https://curecurrent.com/trials/effect-of-continuous-glucose-monitoring-system-alerts-on-diabetes-management-in-the-hospital-10431https://curecurrent.com/trials/assessment-of-individual-follow-up-by-coaching-program-for-type-1-diabetes-children-10432https://curecurrent.com/trials/hong-kong-gestational-diabetes-register-hkgdr-10433https://curecurrent.com/trials/magdi-diversion-feasibility-study-10434https://curecurrent.com/trials/lactic-acidosis-and-prior-metformin-treatment-10435https://curecurrent.com/trials/effect-of-mesenchymal-stem-cells-on-healing-of-foot-ulcers-in-diabetes-patients-10436https://curecurrent.com/trials/prediction-of-heart-failure-and-cognitive-decline-in-type-2-diabetes-10437https://curecurrent.com/trials/study-evaluating-sars-cov-2-covid-19-humoral-response-after-bnt162b2-vaccine-in-immunocompromised-adults-compared-to-hea-10438https://curecurrent.com/trials/edx110-efficacy-and-safety-in-the-management-of-hard-to-heal-wounds-10439https://curecurrent.com/trials/study-to-prevent-dysglycemia-in-women-with-gdm-10440https://curecurrent.com/trials/a-study-on-the-effect-of-cgm-alone-on-glycemic-metrics-in-type-2-diabetes-patients-not-using-insulin-without-additional-10441https://curecurrent.com/trials/the-effect-of-colchicine-on-insulin-sensitivity-in-individuals-with-type-1-diabetes-and-systemic-low-grade-inflammation-10442https://curecurrent.com/trials/exercises-on-children-and-adolescents-with-type-1-diabetes-mellitus-t1dm-10443https://curecurrent.com/trials/impact-of-long-alimentary-limb-or-long-biliary-limb-roux-en-y-gastric-bypass-on-type-2-diabetes-remission-in-severely-ob-10444https://curecurrent.com/trials/turtle-therapy-on-hba1c-and-self-efficacy-levels-with-type-2-diabetes-10445https://curecurrent.com/trials/a-phase-ib-study-of-azd5004-in-chinese-participants-with-overweight-obesity-with-or-without-type-2-diabetes-mellitus-10446https://curecurrent.com/trials/initiation-of-continuous-glucose-monitoring-in-adults-with-type-2-diabetes-treated-with-basal-insulin-in-italy-10447https://curecurrent.com/trials/exploration-of-the-lipid-metabolism-during-the-diabetic-pregnancies-10448https://curecurrent.com/trials/a-prospective-randomnised-controlled-trial-comparing-overall-patient-compliance-in-a-bariatric-surgical-pathway-using-th-10449https://curecurrent.com/trials/urinary-proteomics-to-guide-early-intervention-to-prevent-complications-in-type-2-diabetes-a-feasibility-study-10450https://curecurrent.com/trials/efficacy-and-safety-of-thdb0206-compared-to-insulin-lispro-injection-in-participants-with-type-2-diabetes-10451https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-effects-of-akkermansia-muciniphila-and-berberine-on-prediabetes-among-obese-subjects-10452https://curecurrent.com/trials/moe-and-dnse-effects-on-balance-and-activities-of-daily-living-diabetic-peripheral-neuropathy-10453https://curecurrent.com/trials/impact-of-diabetes-mellitus-on-retinal-microvasculature-in-patients-without-clinical-retinopathy-using-optical-coherence-10454https://curecurrent.com/trials/effects-of-nurse-counselling-in-the-improvement-of-the-type1-diabetes-control-in-adolescents-10455https://curecurrent.com/trials/stimulated-glucagon-as-a-biomarker-of-hypoglycemic-risk-in-type-1-diabetes-10456https://curecurrent.com/trials/metabolic-risk-following-gestational-diabetes-mellitus-10457https://curecurrent.com/trials/exercise-effects-on-pain-sleep-and-depression-in-diabetic-peripheral-neuropathy-10458https://curecurrent.com/trials/efficacy-and-tolerability-of-a-specialized-food-products-for-dietary-therapeutic-and-preventive-nutrition-based-on-ice-c-10459https://curecurrent.com/trials/diactive-1-scaled-up-personalized-mhealth-program-for-youth-with-type-1-diabetes-10460https://curecurrent.com/trials/isglt2-inhibitor-and-a-idpp-4-inhibitor-in-treatment-of-type-2-diabetes-mellitus-in-patients-treated-with-metformin-tria-10461https://curecurrent.com/trials/efficacy-and-safety-of-an-intelligent-insulin-dosing-decision-support-system-for-glycemic-control-in-patients-with-type-10462https://curecurrent.com/trials/genetics-of-response-to-canagliflozin-10463https://curecurrent.com/trials/digital-diabetes-self-management-education-and-support-for-patients-with-type-2-diabetes-10464https://curecurrent.com/trials/efficacy-and-safety-of-the-n0750-compared-to-monotherapies-in-the-treatment-of-painful-diabetic-peripheral-neuropathy-10465https://curecurrent.com/trials/dual-hormone-artificial-pancreas-versus-single-hormone-under-exercise-and-a-meal-challenge-10466https://curecurrent.com/trials/effects-of-core-strengthening-exercises-with-diapgragmatic-breathing-versus-core-strengthening-exercises-with-pilate-bre-10467https://curecurrent.com/trials/phase-iii-trial-of-sglt2-inhibitor-and-thiazolidinedione-fixed-dose-combination-vs-monotherapy-in-type-2-diabetes-patien-10468https://curecurrent.com/trials/smart-family-doctor-assisted-comprehensive-management-of-secondary-prevention-among-post-revascularization-patients-10469https://curecurrent.com/trials/minimal-offloading-dressing-for-the-treatment-of-plantar-diabetes-related-foot-ulcers-10470https://curecurrent.com/trials/efficacy-and-safety-of-maridebart-cafraglutide-in-adult-participants-in-japan-who-have-obesity-disease-10471https://curecurrent.com/trials/maternal-exercise-timing-to-optimise-postprandial-glucose-in-type-1-diabetes-10472https://curecurrent.com/trials/lactoferrin-enriched-dairy-product-in-gestational-diabetes-10473https://curecurrent.com/trials/decide-cv-using-ai-10474https://curecurrent.com/trials/efficacy-evaluation-of-glimepiride-in-patients-with-type-2-diabetes-mellitus-and-chronic-heart-failure-with-reduced-ejec-10475https://curecurrent.com/trials/mobile-application-delivered-resistance-program-for-children-and-adolescents-with-type-1-diabetes-diactive-1-10476https://curecurrent.com/trials/an-analysis-to-assess-non-adherence-in-people-with-type-2-diabetes-10477https://curecurrent.com/trials/canagliflozin-and-myocardial-fibrosis-10478https://curecurrent.com/trials/safety-and-tolerability-evaluationof-phascolarcobacterium-faecium-10479https://curecurrent.com/trials/effects-of-long-duration-cycling-in-people-with-type-1-diabetes-10480https://curecurrent.com/trials/a-study-of-mobile-medical-supportive-care-program-for-family-caregivers-with-dementia-combined-with-diabetes-10481https://curecurrent.com/trials/sexual-activity-and-hypoglycemia-risk-in-adults-with-type-1-or-type-2-diabetes-using-insulin-therapy-and-continuous-gluc-10482https://curecurrent.com/trials/dietitian-nutritionist-vs-day-hospital-in-the-metabolic-control-of-patients-with-type-2-diabetes-10483https://curecurrent.com/trials/active-anti-diabetic-treatment-plus-chemotherapy-for-pancreatic-cancer-related-diabetes-10484https://curecurrent.com/trials/mannitol-induced-release-of-copeptin-in-healthy-adults-and-patients-with-polyuria-polydipsia-syndrome-mars-study-10485https://curecurrent.com/trials/efficacy-and-safety-of-thdb0206-compared-to-insulin-lispro-injection-in-participants-with-type-1-diabetes-10486https://curecurrent.com/trials/efficacy-of-periodontal-treatment-on-glycaemic-control-in-diabetic-patients-10487https://curecurrent.com/trials/global-kidney-patient-trials-network-10488https://curecurrent.com/trials/study-to-evaluate-clinical-efficacy-and-safety-of-nuvastatic-c5osew5050esa-in-diabetic-retinopathy-10489https://curecurrent.com/trials/nafld-in-diabetes-type-2-in-primary-care-10490https://curecurrent.com/trials/activate-tennessee-a-chw-supported-program-for-patient-activation-10491https://curecurrent.com/trials/hypnodiacare-trial-a-randomized-controlled-study-of-hypnosis-integrated-diabetes-self-management-intervention-10492https://curecurrent.com/trials/what-is-the-role-of-triglyceride-glucose-index-as-a-predictive-marker-for-insulin-resistance-in-pre-diabetic-chronic-kid-10493https://curecurrent.com/trials/efficacy-and-safety-of-hdm1005-in-chinese-obesity-or-overweight-patients-without-diabetes-10494https://curecurrent.com/trials/diabetes-intervention-involving-person-centred-nutritional-education-10495https://curecurrent.com/trials/phase-iii-clinical-studies-on-poly-herbal-anti-diabetic-formulation-10496https://curecurrent.com/trials/t1d-risk-assessment-in-kids-with-relatives-10497https://curecurrent.com/trials/ai-wound-alert-home-management-for-recurrent-dfu-10498https://curecurrent.com/trials/therapeutic-outcomes-of-using-complementary-hand-based-treatment-in-diabetes-10499https://curecurrent.com/trials/perineural-injections-of-incobotulinumtoxin-a-for-diabetic-neuropathic-pain-of-the-lower-extremities-10500https://curecurrent.com/trials/short-term-effects-of-sucralose-and-saccharin-on-blood-sugar-and-gut-microbiota-in-type-2-diabetes-10501https://curecurrent.com/trials/effect-of-apelin-on-insulin-sensitivity-in-type-2-diabetic-volunteers-10502https://curecurrent.com/trials/oral-sucrosomial-vitamin-b12-in-the-management-of-b12-deficiency-among-metformin-treated-type-2-diabetes-patients-10503https://curecurrent.com/trials/combined-effects-of-inf-and-oep-in-patients-with-diabetic-peripheral-neuropathy-10504https://curecurrent.com/trials/naff-arabic-validation-study-10505https://curecurrent.com/trials/feasibility-of-self-treatment-of-painful-diabetic-neuropathy-using-electrical-vasomotor-nerve-stimulation-10506https://curecurrent.com/trials/fovea-sparing-ilm-peeling-in-diabetic-patients-10507https://curecurrent.com/trials/effect-of-acute-protein-supplementation-in-diabetic-patients-10508https://curecurrent.com/trials/the-effect-of-laughter-yoga-in-type-2-diabetes-patients-10509https://curecurrent.com/trials/sglt2-inhibitors-and-survival-in-lung-cancer-patients-with-diabetes-10510https://curecurrent.com/trials/therapeutic-efficacy-and-safety-evaluation-of-ai-in-the-management-of-diabetes-a-rct-trial-10511https://curecurrent.com/trials/effect-of-a-collagen-hydrolysate-on-postprandial-blood-glucose-profile-gastric-emptying-and-glp-1-release-in-normoglycem-10512https://curecurrent.com/trials/evaluation-of-correlations-between-volatile-organic-compounds-and-venous-blood-glucose-in-subjects-with-type-2-diabetes-10513https://curecurrent.com/trials/smart-mdi-study-cip343-10514https://curecurrent.com/trials/antenatal-myo-inositol-supplementation-in-pre-existing-diabetes-10515https://curecurrent.com/trials/the-effect-of-aromatherapy-foot-massage-on-neuropathic-pain-in-patients-with-type2-diabetes-10516https://curecurrent.com/trials/mdt-conferences-for-people-with-diabetes-and-multimorbidity-10517https://curecurrent.com/trials/mindfulness-based-interventions-on-stress-anxiety-and-depression-symptoms-in-diabetic-patients-10518https://curecurrent.com/trials/multicenter-study-on-early-arterial-changes-in-prediabetic-patients-evaluated-by-ultra-high-frequency-ultrasound-10519https://curecurrent.com/trials/a-biological-atlas-of-severe-obesity-biological-tissue-collection-10520https://curecurrent.com/trials/association-of-sglt2-inhibitors-therapy-with-elastographic-and-molecular-markers-of-liver-injury-in-type-2-diabetes-10521https://curecurrent.com/trials/the-avelle-negative-pressure-wound-therapy-system-on-chronic-wounds-10522https://curecurrent.com/trials/efficacy-and-safety-of-madalena-association-in-the-treatment-of-type-ii-diabetes-mellitus-10523https://curecurrent.com/trials/to-evaluate-the-beneficial-effect-of-probiotics-on-dkd-patients-and-the-role-of-gut-microbiota-modulation-10524https://curecurrent.com/trials/cgm-accuracy-in-pregnancy-study-10525https://curecurrent.com/trials/mechanisms-underlying-sglt2i-kidney-effect-in-dkd-progression-10526https://curecurrent.com/trials/surgery-versus-best-medical-management-for-the-long-term-remission-of-type-2-diabetes-and-related-diseases-remission-10527https://curecurrent.com/trials/efficacy-and-safety-of-piemonte-association-in-the-treatment-of-type-ii-diabetes-mellitus-10528https://curecurrent.com/trials/the-daytime-circadian-rhythm-in-exhaled-volatile-organic-compounds-in-people-living-without-and-diabetes-10529https://curecurrent.com/trials/a-pilot-study-of-the-effectiveness-of-foot-ankle-and-walking-exercises-in-patients-with-diabetes-mellitus-10530https://curecurrent.com/trials/smart-family-doctor-assisted-comprehensive-management-of-secondary-prevention-among-post-coronary-artery-bypass-graft-pa-10531https://curecurrent.com/trials/assessing-pharmacokinetics-and-pharmacodynamics-of-daily-enteric-coated-aspirin-in-patients-with-stable-diabetes-10532https://curecurrent.com/trials/efficacy-and-safety-of-berlim-25-20-association-in-the-treatment-of-type-ii-diabetes-mellitus-and-dyslipidemia-10533https://curecurrent.com/trials/the-cando-canadian-donor-milk-trial-10534https://curecurrent.com/trials/autologous-dendritic-cell-as-adjunct-therapy-for-diabetic-kidney-disease-10535https://curecurrent.com/trials/research-study-in-japan-to-compare-dasiglucagon-with-glucagon-in-treating-very-low-levels-of-blood-sugar-in-asian-adults-10536https://curecurrent.com/trials/carotid-doppler-screening-for-subclinical-atherosclerosis-in-diabetic-ckd-patients-10537https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-canada-as-part-of-local-clinica-10538https://curecurrent.com/trials/uk-imaging-diabetes-study-seeing-diabetes-clearly-10539https://curecurrent.com/trials/characterization-of-retinal-disease-progression-in-eyes-with-non-proliferative-diabetic-retinopathy-in-diabetes-type-2-u-10540https://curecurrent.com/trials/the-effect-of-motivational-interviewing-on-treatment-adherence-self-efficacy-and-satisfaction-in-individuals-with-diabet-10541https://curecurrent.com/trials/bioequivalence-study-of-test-product-t-of-ertugliflozin-metformin-7-5-mg-1000-mg-film-coated-tablets-and-reference-produ-10542https://curecurrent.com/trials/bioequivalence-study-to-compare-empagliflozin-metformin-25-mg-1000-mg-extended-release-tablet-versus-synjardy-xr-tablets-10543https://curecurrent.com/trials/characteristics-of-marrow-fatty-cells-in-the-ageing-of-bone-and-joints-osteoarthritis-and-osteoporosis-10544https://curecurrent.com/trials/efficacy-and-safety-of-hrs-7535-tablets-in-t2dm-subjects-poorly-controlled-with-metformin-and-sglt2i-10545https://curecurrent.com/trials/optimising-the-delivery-of-diabetes-distress-informed-care-for-its-prevention-detection-and-management-in-adults-with-ty-10546https://curecurrent.com/trials/type-2-diabetes-secondary-prevention-10547https://curecurrent.com/trials/type-1-diabetes-mindfulness-yoga-stress-health-quality-glycemic-i-ndex-10548https://curecurrent.com/trials/a-research-study-to-look-at-how-faster-aspart-works-in-chinese-people-with-type-1-diabetes-or-type-2-diabetes-10549https://curecurrent.com/trials/type-2-diabetes-and-associated-factors-in-mexico-10550https://curecurrent.com/trials/effect-of-omega3-supplementation-in-diabetic-retinopathy-10551https://curecurrent.com/trials/validity-and-reliability-of-the-incremental-shuttle-walk-test-in-type-2-diabetes-mellitus-10552https://curecurrent.com/trials/diabetic-ketoacidosis-from-new-sglt2i-can-genomics-estimate-risk-10553https://curecurrent.com/trials/precision-mental-health-in-diabetes-subtypes-of-mental-health-trajectories-and-patterns-with-glycaemic-control-10554https://curecurrent.com/trials/gestational-lifestyle-outcomes-wellness-10555https://curecurrent.com/trials/value-of-glycated-albumin-in-intervention-of-glycemic-control-in-chinese-patients-with-type-2-diabetes-10556https://curecurrent.com/trials/integrated-tcm-western-medicine-strategy-for-long-distance-diabetes-management-10557https://curecurrent.com/trials/precision-subclassification-of-mental-health-in-diabetes-digital-twins-for-precision-mental-health-to-track-subgroups-10558https://curecurrent.com/trials/adaptive-cognitive-training-on-cognitive-function-in-elderly-diabetes-patients-in-the-community-10559https://curecurrent.com/trials/research-study-to-compare-a-new-medicine-fast-acting-insulin-aspart-to-another-medicine-insulin-aspart-in-chinese-people-10560https://curecurrent.com/trials/effect-of-a-food-supplement-on-glycemic-parameters-in-patients-with-impaired-glucose-metabolism-10561https://curecurrent.com/trials/trajectories-in-insulin-sensitivity-across-menstrual-cycles-in-women-with-type-1-diabetes-10562https://curecurrent.com/trials/preoperative-evaluation-of-gastric-contents-by-antral-ultrasound-in-diabetic-patients-10563https://curecurrent.com/trials/triglyceride-glucose-and-tgi-bmi-indices-compared-with-homa-ir-10564https://curecurrent.com/trials/effect-of-diabetic-foot-exercises-on-peripheral-vascular-status-in-type-2-diabetes-mellitus-patients-10565https://curecurrent.com/trials/safety-and-efficacy-of-insulin-degludec-insulin-aspart-in-patients-with-t2dm-10566https://curecurrent.com/trials/foot-ankle-exercise-and-walking-exercise-on-diabetes-mellitus-patients-10567https://curecurrent.com/trials/validation-of-a-computerised-adaptive-test-for-measuring-caregiver-well-being-10568https://curecurrent.com/trials/assessing-pharmacokinetics-and-pharmacodynamics-of-daily-enteric-coated-aspirin-in-patients-with-stable-diabetes-ii-10569https://curecurrent.com/trials/comparison-of-insulin-s-injection-before-or-after-the-meal-in-type-1-diabetic-patients-treated-with-insulin-pump-10570https://curecurrent.com/trials/improving-oral-and-systemic-health-in-individuals-with-prediabetes-through-personalized-oral-hygiene-advice-provided-by-10571https://curecurrent.com/trials/sex-specific-differences-in-the-association-between-leg-fat-and-diabetes-risk-10572https://curecurrent.com/trials/evaluation-of-rocker-soles-in-diabetis-10573https://curecurrent.com/trials/whey-protein-pre-load-and-postprandial-glycemia-in-pregnancy-10574https://curecurrent.com/trials/lactate-and-glycerol-contribution-to-gluconeogenesis-10575https://curecurrent.com/trials/the-efficacy-of-intravitreal-aflibercept-injection-in-improvement-of-retinal-nonperfusion-in-diabetic-retinopathy-10576https://curecurrent.com/trials/aquacel-ag-extra-and-cutimed-sorbact-dressing-in-the-management-of-venous-leg-ulcers-over-a-12-week-period-10577https://curecurrent.com/trials/homburg-cream-sugar-study-10578https://curecurrent.com/trials/prediabetes-and-metabolic-parameters-among-young-adults-at-assiut-university-hospital-10579https://curecurrent.com/trials/ai-based-lifestyle-guidance-study-10580https://curecurrent.com/trials/the-treatment-of-patients-with-type-1-diabetes-mellitus-with-autologous-tolerogenic-dendritic-cells-10581https://curecurrent.com/trials/hydration-to-optimize-metabolism-10582https://curecurrent.com/trials/prevalence-of-nafld-in-t2dm-patients-10583https://curecurrent.com/trials/multiorgan-multi-parametric-mri-study-10584https://curecurrent.com/trials/evaluation-of-perioperative-myocardial-injury-in-patients-undergoing-below-knee-lower-extremity-surgery-10585https://curecurrent.com/trials/longitudinal-assessment-of-multiple-organs-in-patients-with-type-2-diabetes-10586https://curecurrent.com/trials/a-phase-iii-clinical-study-to-assess-the-efficacy-and-safety-of-gzr4-in-insulin-naive-subjects-with-type-2-diabetes-mell-10587https://curecurrent.com/trials/phase-1-study-of-ct-996-in-overweight-obese-participants-and-patients-with-type-2-diabetes-mellitus-10588https://curecurrent.com/trials/red-bean-and-tomato-snack-bar-formulations-as-a-healthy-snack-for-diabetes-mellitus-patients-10589https://curecurrent.com/trials/metabolic-risk-and-life-style-factors-in-women-with-previous-gestational-diabetes-mellitus-gdm-10590https://curecurrent.com/trials/nudge-based-shared-decision-making-and-self-management-in-type-2-diabetes-a-randomized-trial-10591https://curecurrent.com/trials/pharmacokinetic-and-safety-study-of-gzr4-injection-in-subjects-with-hepatic-impairment-10592https://curecurrent.com/trials/anti-atherosclerotic-efficacy-of-selected-antidiabetic-drugs-in-patients-with-coronary-artery-disease-and-pre-diabetes-10593https://curecurrent.com/trials/noninvasive-evaluation-of-fetal-hyperinsulinemia-with-ultrasound-radiomics-10594https://curecurrent.com/trials/islet-cell-transplantation-in-patients-with-type-i-diabetes-with-previous-kidney-transplantation-10595https://curecurrent.com/trials/cold-atmospheric-plasma-therapy-versus-standard-wound-care-in-diabetic-foot-and-venous-leg-ulcers-10596https://curecurrent.com/trials/extreme-phenotypes-to-identify-susceptibility-of-patients-living-with-type-2-to-diabetes-related-complications-10597https://curecurrent.com/trials/effectiveness-of-weight-loss-methods-on-lifespan-for-metabolic-syndrome-10598https://curecurrent.com/trials/a-first-in-human-study-of-hcr-188-in-overweight-or-obese-otherwise-healthy-volunteers-without-type-2-diabetes-10599https://curecurrent.com/trials/cognitive-screening-and-multidomain-intervention-targeting-cognitive-decline-in-type-2-diabetes-the-brain-care-study-10600https://curecurrent.com/trials/effects-of-oral-sodium-butyrate-supplementation-on-body-weight-reduction-in-overweight-obese-individuals-with-and-withou-10601https://curecurrent.com/trials/a-phase-iiib-clinical-study-to-assess-the-efficacy-and-safety-of-gzr4-in-subjects-with-type-2-diabetes-mellitus-treated-10602https://curecurrent.com/trials/a-phase-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-gzr18-injection-in-adult-type-2-diabetes-mellitus-10603https://curecurrent.com/trials/the-efficacy-and-safety-of-empagliflozin-linagliptin-and-empagliflozin-metformin-therapy-in-reduction-of-body-weight-in-10604https://curecurrent.com/trials/high-throughput-large-model-based-ai-assisted-diagnosis-using-oct-10605https://curecurrent.com/trials/a-phase-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-gzr18-injection-in-subjects-with-type-2-diabetes-melli-10606https://curecurrent.com/trials/effects-of-milk-probiotics-intervention-on-blood-glucose-control-middle-aged-and-elderly-people-with-pre-diabetes-10607https://curecurrent.com/trials/multi-omics-mechanisms-of-lifestyle-intervention-in-regulating-blood-glucose-10608https://curecurrent.com/trials/establishment-of-hong-kong-diabesity-register-10609https://curecurrent.com/trials/a-phase-iii-clinical-study-to-assess-the-efficacy-and-safety-of-gzr4-in-type-2-diabetes-mellitus-subjects-t2dm-treated-w-10610https://curecurrent.com/trials/combined-effects-of-foot-ankle-therapeutic-exercises-and-mindful-walking-in-patients-with-diabetic-polyneuropathy-10611https://curecurrent.com/trials/phase-ii-clinical-study-on-the-efficacy-and-safety-of-the-combination-of-cadonilimab-and-capecitabine-in-adjuvant-therap-10612https://curecurrent.com/trials/to-evaluate-clinical-efficacy-and-safety-of-diabetes-specific-formula-nutren-diabetes-10613https://curecurrent.com/trials/efficacy-and-safety-of-the-met-sglt-2i-glp-1ra-in-patients-with-type-2-diabetes-with-poor-glycemic-control-10614https://curecurrent.com/trials/pde3b-in-metabolic-regulation-10615https://curecurrent.com/trials/peking-university-birth-cohort-in-weifang-pkubc-wf-10616https://curecurrent.com/trials/hf-prevalence-and-evolution-of-hf-in-dm-ii-patients-at-high-risk-10617https://curecurrent.com/trials/bedside-bone-biopsy-in-diabetic-foot-osteomyelitis-10618https://curecurrent.com/trials/the-use-of-the-dexcom-g6-in-commercial-pilots-with-insulin-treated-diabetes-10619https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cell-secretome-administration-in-severe-erectile-dysfunction-non-responsive-to-sildenafi-10620https://curecurrent.com/trials/impact-of-metformin-on-peripheral-arterial-calcification-in-type-1-diabetes-10621https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-gzr102-injection-and-gzr18-injection-in-type-2-diabetes-mellitus-10622https://curecurrent.com/trials/clamp-study-to-estimate-the-relative-potency-of-gzr33-versus-insulin-degludec-at-steady-state-10623https://curecurrent.com/trials/whatsapp-based-and-family-involved-diabetes-self-management-education-study-10624https://curecurrent.com/trials/a-phase-iii-clinical-study-to-assess-the-efficacy-and-safety-of-gzr4-in-subjects-with-type-2-diabetes-mellitus-treated-w-10625https://curecurrent.com/trials/genetic-and-epigenetic-mechanisms-of-developing-gestational-diabetes-mellitus-and-its-effects-on-the-fetus-10626https://curecurrent.com/trials/dpp4-inhibitor-intervention-on-post-stroke-cognitive-impairment-in-ischemic-stroke-patients-with-type-2-diabetes-10627https://curecurrent.com/trials/effect-of-using-bitter-melon-blueberries-and-cranberries-on-hba1c-and-diabetes-symptom-levels-10628https://curecurrent.com/trials/sarcopenia-in-gestational-diabetes-10629https://curecurrent.com/trials/phase-i-study-to-evaluate-the-pharmacokinetics-and-safety-after-co-administration-of-l03rd1-and-l03rd2-or-administration-10630https://curecurrent.com/trials/evaluation-of-serum-and-oct-biomarkers-in-patients-with-dme-treated-with-anti-vegf-or-dexamethasone-implant-10631https://curecurrent.com/trials/multicentric-rct-comparing-high-purity-type-i-collagen-skin-substitute-vs-dhacm-in-treatment-of-diabetic-foot-ulcers-10632https://curecurrent.com/trials/effect-of-hybrid-closed-loop-systems-on-cardiovascular-markers-in-type-1-diabetes-10633https://curecurrent.com/trials/immune-biomarkers-of-residual-beta-cell-mass-in-type-1-diabetes-10634https://curecurrent.com/trials/buzzy-and-tickleflex-in-reducing-insulin-injection-pain-and-fear-10635https://curecurrent.com/trials/therapeutic-education-of-the-patients-diabetics-imprisoned-at-the-paris-jail-10636https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-da-2811-when-added-to-ongoing-bt-1-and-bt-2-combination-therapy-in-10637https://curecurrent.com/trials/aspirin-twice-a-day-in-patients-with-diabetes-and-acute-coronary-syndrome-10638https://curecurrent.com/trials/efficacy-and-safety-study-of-sulfonylureas-in-neonatal-diabetes-mellitus-10639https://curecurrent.com/trials/evaluating-atherosclerotic-disease-progression-in-patients-with-diabetes-mellitus-10640https://curecurrent.com/trials/evaluation-of-the-impact-of-a-therapeutic-education-program-for-children-with-type-1-diabetes-10641https://curecurrent.com/trials/procedure-for-duodenal-ileal-diversion-with-a-sleeve-gastrectomy-for-patients-with-obesity-and-type-2-diabetes-mellitus-10642https://curecurrent.com/trials/preoperative-carbohydrate-loading-in-diabetes-mellitus-10643https://curecurrent.com/trials/effectiveness-of-digital-health-intervention-on-community-health-care-in-middle-aged-and-older-population-in-taiwan-10644https://curecurrent.com/trials/oct-based-dapt-cessation-in-hbr-patients-10645https://curecurrent.com/trials/effect-of-buerger-allen-exercise-on-peripheral-circulation-among-patients-with-type-2-diabetes-mellitus-10646https://curecurrent.com/trials/characterization-of-autoreactive-regulatory-and-conventional-cd4-t-cells-in-recent-onset-type-1-diabetes-and-control-ind-10647https://curecurrent.com/trials/impact-of-a-phone-based-cognitive-and-behavioral-therapy-on-food-addiction-in-patients-with-severe-or-morbid-obesity-10648https://curecurrent.com/trials/the-effect-of-prehospital-combination-of-epinephrine-vasopressin-and-steroid-in-ohca-10649https://curecurrent.com/trials/abnormal-post-partum-glucose-metabolism-after-gestational-diabetes-diagnosed-before-or-after-24-weeks-of-gestation-10650https://curecurrent.com/trials/the-advisor-pro-direct-study-10651https://curecurrent.com/trials/efficacy-and-safety-of-da5221-t-when-added-to-ongoing-da5221-b1-and-da5221-b2-combination-therapy-in-patients-with-type-10652https://curecurrent.com/trials/artificial-intelligence-for-diagnosing-diabetic-retinopathy-in-primary-care-10653https://curecurrent.com/trials/adherence-to-mediterranean-diet-in-type-1-diabetes-initiating-minimed-780g-glucose-metrics-vs-insulin-metrics-is-there-a-10654https://curecurrent.com/trials/vitamin-d-nerve-growth-factor-and-nerve-conduction-studies-in-adult-male-type-2-diabetic-neuropathy-patients-10655https://curecurrent.com/trials/cardiovascular-and-renal-endpoints-with-flozins-an-observational-prospective-study-in-ckd-hfpef-patients-10656https://curecurrent.com/trials/prevalence-of-sleep-apnea-syndrome-in-patients-with-type-1-diabetes-10657https://curecurrent.com/trials/effect-of-hawthorn-vinegar-black-mulberry-syrup-and-green-tea-on-oral-mucositis-10658https://curecurrent.com/trials/effect-of-levosulpiride-on-retinal-alterations-in-patients-with-diabetic-retinopathy-and-diabetic-macular-edema-10659https://curecurrent.com/trials/diabetes-mellitus-symptoms-related-to-physical-competence-10660https://curecurrent.com/trials/high-resolution-high-speed-multimodal-ophthalmic-imaging-10661https://curecurrent.com/trials/screening-of-liver-fibrosis-using-blood-tests-in-patients-with-type-2-diabetes-mellitus-10662https://curecurrent.com/trials/screening-for-type-2-diabetes-by-oral-glucose-tolerance-test-in-the-population-groups-not-diagnosed-by-fasting-blood-glu-10663https://curecurrent.com/trials/the-feasibility-of-expectant-management-versus-induction-at-38-weeks-among-individuals-with-gestational-diabetes-mellitu-10664https://curecurrent.com/trials/the-impact-of-two-different-insulin-dose-calculation-on-postprandial-glycemia-after-mixed-meal-10665https://curecurrent.com/trials/single-session-vs-multiple-session-panretinal-photocoagulation-for-treatment-of-proliferative-diabetic-retinopathy-10666https://curecurrent.com/trials/tandem-freedom-feasibility-study-1-10667https://curecurrent.com/trials/ganagliflozin-on-the-progression-of-kidney-disease-in-subjects-with-type-2-diabetes-mellitus-and-chronic-kidney-disease-10668https://curecurrent.com/trials/a-study-comparing-shr-3167-and-insulin-degludec-in-type-2-diabetic-subjects-treated-with-basal-insulin-with-or-without-o-10669https://curecurrent.com/trials/the-foot-in-your-nose-study-links-between-nasal-staphylococcus-aureus-colonies-and-diabetic-foot-lesion-infections-10670https://curecurrent.com/trials/pharmacodynamic-comparison-of-truncal-blocks-in-patients-with-or-without-metabolic-disease-kidney-failure-diabetes-10671https://curecurrent.com/trials/exercise-training-and-cardiovascular-function-in-obesity-and-in-type-2-diabetes-10672https://curecurrent.com/trials/fructosamines-and-gestational-diabetes-fructo-10673https://curecurrent.com/trials/effect-of-foot-ankle-exercise-using-elastic-band-10674https://curecurrent.com/trials/insulin-resistance-in-gestational-diabetes-mellitus-10675https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-da-5218-in-patients-with-type-2-diabetes-10676https://curecurrent.com/trials/high-purity-type-i-collagen-based-skin-substitute-vs-dehydrated-human-amnion-chorion-membrane-in-treatment-of-dfus-10677https://curecurrent.com/trials/safety-tolerability-and-effectiveness-of-duodenal-mucosal-rf-vapor-ablation-for-insulin-elimination-in-type-2-diabetes-10678https://curecurrent.com/trials/a-study-of-ly8888ax-in-participants-using-a-connected-insulin-management-platform-10679https://curecurrent.com/trials/rf-vapor-ablation-retreatment-of-duodenal-mucosa-in-non-responders-with-type-2-diabetes-mellitus-10680https://curecurrent.com/trials/efficacy-of-carbonlife-amniotic-tissue-product-in-the-treatment-of-chronic-wounds-10681https://curecurrent.com/trials/evaluating-safe-ketone-thresholds-to-minimise-ketosis-in-people-with-type-1-diabetes-using-dapagliflozin-10682https://curecurrent.com/trials/harambee-integrated-community-based-hiv-ncd-care-microfinance-groups-in-kenya-10683https://curecurrent.com/trials/efficacy-of-fdc-regimen-of-dapagliflozin-metformin-compared-to-co-administered-dual-therapy-on-glycemic-control-satisfac-10684https://curecurrent.com/trials/a-study-of-bgm0504-in-participants-with-type-2-diabetes-in-indonesia-10685https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-chinese-participants-with-type-2-diabetes-surpass-cn-mono-10686https://curecurrent.com/trials/a-research-study-looking-at-new-protein-based-tablets-in-healthy-men-oral-formulation-iv-10687https://curecurrent.com/trials/a-study-of-ct-388-in-otherwise-healthy-overweight-and-obese-adults-and-patients-with-type-2-diabetes-mellitus-10688https://curecurrent.com/trials/effectiveness-of-dapagliflozin-for-weight-loss-10689https://curecurrent.com/trials/epidemiology-of-diabetes-interventions-and-complications-edic-10690https://curecurrent.com/trials/bioequivalence-study-to-compare-empagliflozin-linagliptin-metformin-hcl-25mg-5mg-1000mg-extended-release-tablets-versus-10691https://curecurrent.com/trials/health-promotion-model-based-education-and-motivational-interviewing-for-parents-of-children-with-type-1-diabetes-10692https://curecurrent.com/trials/dapagliflozin-sc0062-and-prevention-of-renal-injury-a-randomized-evaluation-10693https://curecurrent.com/trials/retrospective-multicenter-single-arm-observational-study-with-data-from-patients-with-t2dm-with-malnutrition-or-at-risk-10694https://curecurrent.com/trials/ckd-awareness-referrals-education-and-support-intervention-for-early-stage-ckd-10695https://curecurrent.com/trials/additional-effects-of-neural-mobilization-on-pain-balance-and-quality-of-life-in-diabetic-neuropathy-10696https://curecurrent.com/trials/safety-of-dapagliflozin-forxiga-in-patient-with-type-2-diabetes-mellitus-t2dm-in-vietnam-from-a-post-marketing-surveilla-10697https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacodynamics-of-azd4144-in-participants-with-obesity-10698https://curecurrent.com/trials/inter-and-intraindividual-variability-of-the-acute-glucose-response-to-exercise-in-healthy-adults-and-people-living-with-10699https://curecurrent.com/trials/whatsapp-based-education-program-for-stroke-patients-10700https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-israel-as-part-of-local-clinica-10701https://curecurrent.com/trials/lifestyle-intervention-for-type-2-diabetes-in-primary-care-credoenap-10702https://curecurrent.com/trials/metabolic-impact-of-intermittent-fasting-in-early-type-2-diabetes-10703https://curecurrent.com/trials/observational-study-for-the-characterisation-of-patients-affected-by-any-type-of-diabetes-and-endocrine-disorders-10704https://curecurrent.com/trials/cross-cultural-adaptation-and-validity-of-the-arabic-translated-neuropathy-specific-quality-of-life-questionnaire-10705https://curecurrent.com/trials/chemfoot-debrichem-in-chronic-diabetic-foot-wounds-10706https://curecurrent.com/trials/thai-painpredict-validation-study-10707https://curecurrent.com/trials/effects-of-intranasal-oxytocin-on-sexual-well-being-in-patients-with-arginine-vasopressin-deficiency-and-healthy-control-10708https://curecurrent.com/trials/the-effects-of-oxytocin-and-vasopressin-on-delta-beta-cross-frequency-coupling-10709https://curecurrent.com/trials/interleukin-2-therapy-of-autoimmunity-in-diabetes-itad-10710https://curecurrent.com/trials/impact-of-partially-replacing-wheat-with-millets-or-bengal-gram-flour-in-rotis-on-glycemia-and-prediabetes-reversal-10711https://curecurrent.com/trials/cardiovascular-disease-cvd-constitutes-a-significant-health-challenge-for-individuals-with-type-2-diabetes-mellitus-t2dm-10712https://curecurrent.com/trials/ma-ceal-community-health-ambassador-program-10713https://curecurrent.com/trials/doors-a-research-study-to-understand-how-oral-semaglutide-works-in-people-with-type-2-diabetes-who-change-from-dipeptidy-10714https://curecurrent.com/trials/colostrum-supplements-effect-on-the-physical-performance-and-cognitive-function-10715https://curecurrent.com/trials/cryopreserved-hair-follicles-for-disease-and-cell-replacement-10716https://curecurrent.com/trials/wearable-technology-data-driven-digital-health-coaching-activation-a-mixed-methods-study-10717https://curecurrent.com/trials/platelet-rich-plasma-prp-as-terapeutical-option-in-erectil-disfunction-de-10718https://curecurrent.com/trials/improving-hba1c-levels-by-methylcobalamin-vitamin-in-diabetic-volunteers-10719https://curecurrent.com/trials/effects-of-moderate-carbohydrate-consumption-on-metabolic-and-obstetric-outcomes-in-pregnant-women-with-insulin-treated-10720https://curecurrent.com/trials/telecare-north-diabetes-10721https://curecurrent.com/trials/comparing-the-efficacy-of-metronidazole-and-minocycline-gels-for-the-treatment-of-diabetic-periodontitis-patients-10722https://curecurrent.com/trials/predictive-factors-and-monitoring-strategies-in-steroid-induced-diabetes-10723https://curecurrent.com/trials/disease-modification-outcomes-in-diabetes-a-delphi-study-10724https://curecurrent.com/trials/minimally-invasive-suprachoroidal-drainage-for-the-treatment-of-neovascular-glaucoma-10725https://curecurrent.com/trials/the-effect-of-web-based-birth-preparation-education-given-to-pregnant-women-on-prenatal-attachment-and-fear-of-birth-10726https://curecurrent.com/trials/effectiveness-of-cbd-for-neuropathic-pain-in-diabetic-foot-neuropathy-10727https://curecurrent.com/trials/adaptation-of-redchip-intervention-for-the-portuguese-context-10728https://curecurrent.com/trials/phase-ii-clinical-study-of-hdm1005-injection-in-obese-adults-without-diabetes-mellitus-10729https://curecurrent.com/trials/ppio-007-correlation-analysis-of-type-ii-diabetes-mellitus-on-short-term-and-long-term-outcomes-of-patients-with-esophag-10730https://curecurrent.com/trials/a-phase-i-ii-trial-to-preserve-residual-insulin-secretion-in-children-with-recent-onset-type-1-diabetes-by-giving-verapa-10731https://curecurrent.com/trials/a-preliminary-exploratory-clinical-trial-to-evaluate-the-efficacy-of-npdr-01-eye-drops-in-the-treatment-of-non-prolifera-10732https://curecurrent.com/trials/sglt2-inhibitor-use-after-acute-myocardial-infarction-in-patients-with-type-2-diabetes-a-nationwide-cohort-study-10733https://curecurrent.com/trials/the-improvement-effect-of-henggliejin-on-fatty-liver-in-type-2-diabetes-patients-with-nonalcoholic-fatty-liver-10734https://curecurrent.com/trials/hyperuricemia-as-early-indication-of-ckd-progressing-in-prediabetic-10735https://curecurrent.com/trials/cofrogliptin-and-linagliptin-as-add-on-therapy-to-insulin-in-type-2-diabetes-10736https://curecurrent.com/trials/the-effect-of-individualized-nursing-interventions-on-glycemic-variability-and-self-management-in-type-2-diabetes-10737https://curecurrent.com/trials/the-effect-of-diabetes-m-application-use-versus-conventional-bolus-calculation-in-patients-with-type-1-diabetes-mellitus-10738https://curecurrent.com/trials/meta-analyses-of-the-effect-of-plant-protein-versus-animal-protein-on-cardiometabolic-risk-10739https://curecurrent.com/trials/the-effect-of-motivational-interviewing-on-self-efficacy-and-quality-of-life-in-gestational-diabetes-mellitus-10740https://curecurrent.com/trials/vey-low-energy-ketogenic-therapy-in-adults-with-type-1-diabetes-and-obesity-on-intensive-insulin-therapy-using-advanded-10741https://curecurrent.com/trials/effect-of-visual-presentation-of-atherosclerotic-plaque-on-modification-of-arterial-hypertension-one-year-postpartum-in-10742https://curecurrent.com/trials/food-effect-efficacy-and-safety-of-mkp10241-in-healthy-and-obese-adult-participants-with-and-without-diabetes-10743https://curecurrent.com/trials/predictive-effect-of-tgf-and-ins-pi3k-akt-related-proteins-for-pod-in-diabetes-patients-10744https://curecurrent.com/trials/ms-553-in-diabetic-retinopathy-patients-with-central-involved-macular-edema-10745https://curecurrent.com/trials/assessment-of-non-vascular-risk-factors-for-severity-of-diabetic-foot-ulcers-dfus-10746https://curecurrent.com/trials/effect-of-moringa-oleifera-dehydrated-leaf-powder-on-the-components-of-metabolic-syndrome-in-mexican-adults-10747https://curecurrent.com/trials/a-multicenter-randomized-open-label-parallel-controlled-clinical-study-comparing-the-efficacy-and-safety-of-cofrogliptin-10748https://curecurrent.com/trials/the-timed-t1d-project-10749https://curecurrent.com/trials/relationship-between-diabetes-and-periodontitis-10750https://curecurrent.com/trials/multicenter-rct-of-eye-brain-imaging-in-diabetes-neurovascular-coupling-10751https://curecurrent.com/trials/game-based-education-and-treatment-adherence-in-type-2-diabetes-10752https://curecurrent.com/trials/accuracy-of-a-continuous-ketone-monitoring-ckm-system-in-individuals-with-type-1-diabetes-on-insulin-pump-therapy-10753https://curecurrent.com/trials/menses-change-in-diabetic-girl-10754https://curecurrent.com/trials/study-to-evaluate-hdm1002-tablets-in-adults-with-type-2-diabetes-mellitus-10755https://curecurrent.com/trials/a-study-on-the-short-course-treatment-regimen-containing-pretomanid-for-diabetes-mellitus-complicated-with-rifampicin-re-10756https://curecurrent.com/trials/clinical-and-biological-signs-of-dapagliflozin-overdose-in-icu-patients-with-metformin-poisoning-10757https://curecurrent.com/trials/support-online-training-platform-for-type-1-diabetes-self-management-education-and-support-support-10758https://curecurrent.com/trials/comparison-of-smartguard-vs-temp-target-in-patients-with-type-1-diabetes-users-of-advanced-hybrid-closed-loop-system-ahc-10759https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-in-b00009-injection-in-adults-with-obesity-or-overweight-without-diabetes-m-10760https://curecurrent.com/trials/effect-of-high-intensity-laser-exercise-versus-moderate-intensity-aerobic-exercise-on-diabetic-polyneuropathy-patients-10761https://curecurrent.com/trials/relative-impacts-on-preventative-primary-care-a-longitudinal-evaluation-of-covid-19-phase-1-10762https://curecurrent.com/trials/digital-diabetes-treatment-the-healthy-eating-healthy-patients-trial-10763https://curecurrent.com/trials/retinal-vascular-manifestations-in-patients-with-common-internal-diseases-on-octa-tomography-angiography-10764https://curecurrent.com/trials/support-t-online-training-in-youth-living-with-type-1-diabetes-transitioning-to-adult-care-10765https://curecurrent.com/trials/the-support-pro-online-platform-for-healthcare-professionals-treating-individuals-living-with-t1d-10766https://curecurrent.com/trials/implementation-of-support-in-the-care-of-adults-living-with-type-1-diabetes-10767https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-spain-as-part-of-local-clinical-10768https://curecurrent.com/trials/iglarlixi-vs-idegasp-in-chinese-participants-after-oad-s-10769https://curecurrent.com/trials/safety-study-of-weekly-semaglutide-in-chilean-participants-with-type-2-diabetes-10770https://curecurrent.com/trials/eating-disturbances-in-patients-with-type-1-diabetes-initiating-insulin-therapy-10771https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-saudi-arabia-as-part-of-local-c-10772https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-the-netherlands-as-part-of-loca-10773https://curecurrent.com/trials/glycemia-and-antibiotic-efficacy-in-diabetic-recurrent-utis-10774https://curecurrent.com/trials/glp1-ra-and-periodontitis-10775https://curecurrent.com/trials/effects-of-different-early-intensive-therapies-on-long-term-cell-function-10776https://curecurrent.com/trials/dietary-management-of-gestational-diabetes-10777https://curecurrent.com/trials/a-bioequivalence-study-comparing-two-different-strengths-formulations-of-insulin-lispro-in-patients-with-type-1-diabetes-10778https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-italy-as-part-of-local-clinical-10779https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-denmark-as-part-of-local-clinic-10780https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-japan-as-part-of-local-clinical-10781https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-sweden-as-part-of-local-clinica-10782https://curecurrent.com/trials/coronary-flow-reserve-changes-after-semaglutide-treatment-10783https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-the-united-kingdom-as-part-of-l-10784https://curecurrent.com/trials/a-research-study-looking-at-how-oral-semaglutide-works-in-people-with-type-2-diabetes-in-mexico-as-part-of-local-clinica-10785https://curecurrent.com/trials/ace-reno-pico-cell-matrix-and-its-effect-on-egfr-in-chronic-kidney-diseases-10786https://curecurrent.com/trials/young-adolescents-behaviour-musculoskeletal-health-growth-nutrition-10787https://curecurrent.com/trials/implementation-and-evaluation-of-bump2baby-and-me-programme-for-gestational-diabetes-mellitus-in-routine-maternity-care-10788https://curecurrent.com/trials/phase-1-study-assessing-the-pharmacokinetics-of-nex-22a-in-subjects-with-t2d-10789https://curecurrent.com/trials/phase-2-randomized-study-of-pg-102-vs-placebo-and-semaglutide-in-type-2-diabetes-mellitus-10790https://curecurrent.com/trials/characteristics-of-diabetic-foot-ulcer-patients-10791https://curecurrent.com/trials/efficacy-and-safety-of-the-minimed-780g-advanced-hybrid-closed-loop-system-ahcl-in-patients-with-type-1-diabetes-undergo-10792https://curecurrent.com/trials/anti-viral-action-against-type-1-diabetes-autoimmunity-10793https://curecurrent.com/trials/differing-completion-rates-of-diabetes-education-on-patient-reported-outcomes-10794https://curecurrent.com/trials/type-2-diabetes-post-exercise-arterial-stiffness-10795https://curecurrent.com/trials/the-pressure-relieving-capacity-of-siliconepads-compared-to-felted-foam-to-relieve-caput-metatarsal-2-in-a-population-wi-10796https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-insulin-glargine-300-u-ml-gla-300-in-insulin-na-ve-patients-with-type-2-diabete-10797https://curecurrent.com/trials/a-clinical-efficacy-and-safety-study-of-insulin-glargine-u300-in-chinese-adult-patients-with-uncontrolled-type-2-diabete-10798https://curecurrent.com/trials/remote-ischemic-preconditioning-to-prevent-contrast-induced-kidney-injury-in-diabetic-patients-princes-10799https://curecurrent.com/trials/clinical-study-to-evaluate-efficacy-and-safety-of-allo-asc-dfu-in-patients-with-diabetic-wagner-grade-2-foot-ulcers-10800https://curecurrent.com/trials/evaluation-of-the-clinical-efficacy-and-feasibility-of-digital-foot-care-intervention-strategies-with-different-intensit-10801https://curecurrent.com/trials/may-metformin-be-used-in-renal-failure-10802https://curecurrent.com/trials/efficacity-and-safety-of-metformin-xr-in-ckd-stage-1-to-3-10803https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-glp-1-receptor-agonist-therapy-in-steroid-induced-diabetes-10804https://curecurrent.com/trials/evaluation-of-main-determinants-of-postprandial-glucose-response-in-type-1-diabetes-10805https://curecurrent.com/trials/environmental-factors-on-dfus-incidence-a-mixed-mode-survey-10806https://curecurrent.com/trials/the-effect-of-chlorhexidine-mouthwash-on-postprandial-glucose-response-in-healthy-individuals-10807https://curecurrent.com/trials/evaluation-of-advanced-glycation-end-products-age-and-the-erectile-dysfunction-de-in-diabetic-patients-10808https://curecurrent.com/trials/an-analysis-of-plantar-pressure-distribution-and-postural-balance-parameters-in-individuals-with-diabetic-foot-diagnosis-10809https://curecurrent.com/trials/prediabetes-and-type-2-diabetes-in-aging-10810https://curecurrent.com/trials/dexcom-hybrid-closed-loop-insulin-pump-study-in-type-1-diabetes-10811https://curecurrent.com/trials/impact-of-glycemic-variability-on-people-with-gastrointestinal-cancer-and-diabetes-after-surgery-10812https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-efficacy-of-jy09-compared-with-placebo-in-t2dm-patients-10813https://curecurrent.com/trials/assessment-and-management-of-multiple-drug-use-in-elderly-chronic-disease-patients-10814https://curecurrent.com/trials/association-of-gene-polymorphism-with-susceptibility-to-t2dm-and-the-therapeutic-responses-to-exenatide-in-chinese-patie-10815https://curecurrent.com/trials/control-of-hypertension-and-diabetes-in-minas-gerais-10816https://curecurrent.com/trials/comparing-low-level-laser-and-muscle-energy-techniques-in-diabetic-frozen-shoulder-10817https://curecurrent.com/trials/oxxynea-gs-study-for-glycaemia-management-10818https://curecurrent.com/trials/effect-of-oral-magnesium-supplementation-on-type-ii-diabetes-mellitus-guided-by-serum-ionized-magnesium-level-10819https://curecurrent.com/trials/the-effect-of-semaglutide-on-bone-health-10820https://curecurrent.com/trials/postoperative-euglycemic-ketoacidosis-frequency-in-sodium-glucose-cotransporter-2-inhibitor-users-10821https://curecurrent.com/trials/fake-carbs-practice-with-aid-system-minimed-780g-in-children-and-adolescents-with-t1d-10822https://curecurrent.com/trials/clinical-characteristics-of-neovascular-glaucoma-10823https://curecurrent.com/trials/digital-diabetes-remission-trial-10824https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-efficacy-of-jy09-compared-with-dulaglutide-in-combination-therapy-diabetes-mellitus-type-10825https://curecurrent.com/trials/allopurinol-and-lisinopril-for-diabetic-kidney-protection-a-comparative-study-in-normouricemic-type-2-diabetics-10826https://curecurrent.com/trials/effect-of-macronutrients-on-post-exercise-glycemic-response-in-males-with-type-2-diabetes-10827https://curecurrent.com/trials/real-life-home-glucose-monitoring-over-14-days-in-t2d-patients-with-intensified-therapy-using-insulin-pump-10828https://curecurrent.com/trials/effects-of-vitamin-d-and-prebiotic-supplementation-on-glucose-control-during-pregnancy-10829https://curecurrent.com/trials/testing-a-smart-medication-dispenser-mobili-to-help-people-with-chronic-conditions-take-their-medicine-10830https://curecurrent.com/trials/role-of-metformin-in-posterior-capsule-opacification-10831https://curecurrent.com/trials/effects-of-vitamin-d3-and-prebiotics-supplementation-on-cardiovascular-risk-factors-in-patients-with-type-2-diabetes-10832https://curecurrent.com/trials/phase-i-clinical-study-to-evaluate-the-safety-and-efficacy-of-rgb-5088-in-patients-with-type-1-diabetes-mellitus-10833https://curecurrent.com/trials/smart-health-pregnancy-2-intervention-to-reduce-anaemia-and-cardiometabolic-risk-during-pregnancy-and-in-the-first-year-10834https://curecurrent.com/trials/mangosteen-supplement-as-adjuvant-therapy-with-sitagliptin-metformin-in-iraqi-patients-with-type-2-diabetes-10835https://curecurrent.com/trials/impact-of-rheumatoid-arthritis-on-the-course-of-type-2-diabetes-during-a-longitudinal-follow-up-of-5-years-10836https://curecurrent.com/trials/a-risk-assessment-and-management-program-using-telecare-consultation-among-patients-with-diabetes-mellitus-10837https://curecurrent.com/trials/non-invasive-masld-diagnosis-t2d-remission-biomarkers-10838https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-dapagliflozin-in-patient-with-type-2-diabetes-mellitus-and-hypertension-10839https://curecurrent.com/trials/algae-effects-in-markers-of-cardiovascular-risk-and-gut-microbiome-10840https://curecurrent.com/trials/factors-associated-with-pre-hypertension-among-children-with-type-1-diabetes-mellitus-10841https://curecurrent.com/trials/a-phase-iv-clinical-trial-to-compare-the-efficacy-and-safety-of-metformin-sodium-glucose-cotransporter-2-inhibitor-sglt2-10842https://curecurrent.com/trials/acute-effects-of-cold-induced-shivering-on-24-hour-the-glucose-profile-in-metabolically-compromised-populations-10843https://curecurrent.com/trials/evaluating-the-roles-of-novel-inflammatory-markers-compared-to-mcp-1-in-type-2-diabetic-nephropathy-10844https://curecurrent.com/trials/performance-and-safety-evaluation-of-the-ekiyou-v2-application-in-patients-with-diabetes-using-multiple-daily-insulin-in-10845https://curecurrent.com/trials/isglt2-in-patients-without-dm-with-acute-mi-10846https://curecurrent.com/trials/digital-therapy-for-individualized-intervention-and-management-of-gestational-diabetes-mellitus-10847https://curecurrent.com/trials/efficacy-and-safety-of-henagliflozin-proline-and-metformin-hydrochloride-extended-release-tablets-versus-metformin-table-10848https://curecurrent.com/trials/rapide-the-feasibility-of-a-hybrid-care-model-10849https://curecurrent.com/trials/effect-of-empagliflozin-10-vs-25-mg-on-lv-remodeling-in-diabetic-patients-with-anterior-stemi-with-reduced-lvef-10850https://curecurrent.com/trials/diagnosis-and-physiopathology-of-insulin-allergy-10851https://curecurrent.com/trials/intervention-effects-of-optimized-carbohydrate-diet-in-patients-with-type-2-diabetes-10852https://curecurrent.com/trials/a-randomized-double-blind-multi-center-active-controlled-phase-3-clinical-trial-to-evaluate-the-efficacy-and-safety-of-c-10853https://curecurrent.com/trials/artificial-pancreas-in-latin-america-10854https://curecurrent.com/trials/diet-and-progression-of-ckd-in-patients-with-type-2-diabetes-mellitus-10855https://curecurrent.com/trials/a-study-of-3mg-once-every-two-weeks-administration-of-efsubaglutide-alfa-injection-in-type-2-diabetes-patients-10856https://curecurrent.com/trials/investigation-of-ultrasonographic-measurements-of-lower-extremity-nerves-in-type-2-diabetes-patients-with-peripheral-pol-10857https://curecurrent.com/trials/microperimetry-changes-in-retinal-function-in-macular-disorders-10858https://curecurrent.com/trials/evaluation-of-the-performance-of-an-e-health-system-10859https://curecurrent.com/trials/proof-of-concept-open-label-clinical-trial-to-evaluate-the-safety-and-efficacy-of-the-fitt-device-in-diabetic-foot-ulcer-10860https://curecurrent.com/trials/point-of-care-testing-in-outpatient-diabetes-care-10861https://curecurrent.com/trials/comparative-study-of-negative-pressure-wound-therapy-integrated-with-silver-nanoparticle-spray-versus-negative-pressure-10862https://curecurrent.com/trials/the-effect-of-model-based-d-g-tal-game-on-metabol-c-control-self-eff-c-ency-and-qual-ty-of-l-fe-in-ch-ldren-w-th-type-1-10863https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pk-and-pd-of-ap303-in-dkd-patients-10864https://curecurrent.com/trials/technological-based-personalized-care-intervention-for-supporting-older-people-with-diabetes-mellitus-10865https://curecurrent.com/trials/improving-patient-centered-care-for-diabetes-in-bangladesh-through-dynamic-integration-of-vision-care-on-the-demand-side-10866https://curecurrent.com/trials/improving-patient-centered-care-for-diabetes-in-bangladesh-through-dynamic-integration-of-vision-care-on-the-supply-side-10867https://curecurrent.com/trials/virtual-health-coaching-with-artificial-intelligence-for-glycemic-control-in-type-2-diabetes-10868https://curecurrent.com/trials/cognitive-function-and-mental-health-in-children-and-youth-with-type-1-diabetes-t1d-10869https://curecurrent.com/trials/fastforward-a-prospective-analysis-of-long-term-fasting-and-subsequent-food-reintroduction-in-humans-10870https://curecurrent.com/trials/periodontal-follow-up-and-glycemy-in-patients-with-type-2-diabetes-10871https://curecurrent.com/trials/the-effect-of-the-interdisciplinary-care-approach-on-general-health-parameters-in-older-adults-with-type-2-diabetes-10872https://curecurrent.com/trials/xw004-to-evaluate-the-safety-tolerability-pk-and-pd-of-oral-ecnoglutide-tablet-in-healthy-adults-10873https://curecurrent.com/trials/washed-microbiota-transplantation-for-type-1-diabetes-mellitus-10874https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-efficacy-of-xw003-compared-with-placebo-in-t2dm-patients-10875https://curecurrent.com/trials/study-of-ai-based-prediction-models-for-exercise-induced-gut-microbiota-alterations-in-patients-with-type-2-diabetes-10876https://curecurrent.com/trials/human-versus-analogue-insulin-for-youth-with-type-1-diabetes-in-low-resource-settings-10877https://curecurrent.com/trials/i-wear-evaluating-wearables-and-health-summaries-in-icu-survivors-10878https://curecurrent.com/trials/the-skin-barrier-in-users-of-diabetes-devices-10879https://curecurrent.com/trials/complete-pulpotomy-and-root-canal-treatment-patients-with-irreversible-pulpitis-with-type-2-diabetes-mellitus-10880https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-jw0201-added-on-in-patients-with-type-2-diabetes-mellitus-10881https://curecurrent.com/trials/diabetes-diagnosis-during-acute-admissions-find-it-10882https://curecurrent.com/trials/shanghai-clinical-cohort-of-hyperglycemia-in-pregnancy-10883https://curecurrent.com/trials/earlier-diagnosis-of-peripheral-neuropathy-using-a-simple-screening-tool-act-10884https://curecurrent.com/trials/the-effect-of-oxytocin-on-the-alpha-cell-response-to-hypoglycaemia-in-patients-with-type-1-diabetes-10885https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-jw0201-added-on-in-patients-with-t2dm-10886https://curecurrent.com/trials/healthy-eating-in-women-at-risk-of-gestational-diabetes-10887https://curecurrent.com/trials/vitamine-d-supplementation-in-renal-transplant-recipients-vitale-10888https://curecurrent.com/trials/cardiovascular-kidney-metabolic-syndrome-in-shanghai-zicitizens-10889https://curecurrent.com/trials/a-risk-score-for-prediction-of-gestational-diabetesmellitus-in-china-using-routinely-collected-hospital-data-10890https://curecurrent.com/trials/perception-knowledge-and-attitudes-of-educational-staff-regarding-the-care-of-children-with-type-1-diabetes-evaluation-o-10891https://curecurrent.com/trials/glibentek-in-patients-with-neonatal-diabetes-secondary-to-mutations-in-k-atp-channels-10892https://curecurrent.com/trials/continuous-care-intervention-in-primary-care-to-improve-type-2-diabetes-control-in-terres-de-l-ebre-catalonia-10893https://curecurrent.com/trials/postoperative-gastroesophageal-reflux-symptoms-after-laparoscopic-sleeve-gastrectomy-based-on-the-presence-of-preoperati-10894https://curecurrent.com/trials/research-on-effects-of-drugs-on-body-composition-and-function-with-imaging-in-diabetes-10895https://curecurrent.com/trials/impact-of-neuropathy-on-the-risk-of-semaglutide-induced-gastric-retention-10896https://curecurrent.com/trials/a-phase-3-study-of-hs-20094-in-patients-with-t2dm-10897https://curecurrent.com/trials/remission-of-type-2-diabetes-between-intermittently-scanned-continuous-glucose-monitoring-and-capillary-blood-glucose-mo-10898https://curecurrent.com/trials/multicenter-randomized-trial-of-non-inferiority-between-glyburide-and-insulin-for-the-treatment-of-gestational-diabetes-10899https://curecurrent.com/trials/effect-of-high-fat-high-protein-meal-in-type-1-diabetes-10900https://curecurrent.com/trials/a-phase-3-study-of-hs-20094-in-patients-with-t2dm-inadequately-controlled-with-diet-and-exercise-alone-10901https://curecurrent.com/trials/effects-of-circadian-rhythm-on-glycemic-regulation-during-continuous-moderate-exercise-and-intense-intermittent-disease-10902https://curecurrent.com/trials/determination-of-the-predictive-factors-in-the-reversibility-or-the-aggravation-in-the-disorders-of-the-glucose-metaboli-10903https://curecurrent.com/trials/study-on-the-improvement-of-metabolic-indicators-in-type-1-diabetes-patients-10904https://curecurrent.com/trials/endocan-and-copeptin-serum-levels-in-preterm-neonates-with-respiratory-distress-syndrome-10905https://curecurrent.com/trials/mediterranean-diet-circuit-resistance-training-empagliflozin-in-elderly-with-type-2-diabetes-a-study-protocol-10906https://curecurrent.com/trials/inflammatory-and-hematological-indices-in-diabetic-stemi-patients-undergoing-primary-pci-10907https://curecurrent.com/trials/identification-of-a-score-for-the-assessment-of-intrapancreatic-fat-10908https://curecurrent.com/trials/glucobites-cookies-gynura-procumbens-for-glycemic-control-and-prevention-of-diabetic-foot-ulcer-risk-in-type-2-diabetes-10909https://curecurrent.com/trials/role-of-red-blood-cells-in-cardiovascular-disease-10910https://curecurrent.com/trials/diagnostic-tools-to-establish-the-presence-and-severity-of-peripheral-arterial-disease-in-people-with-diabetes-10911https://curecurrent.com/trials/efficacy-of-glycemic-improvement-project-glitter-study-in-type-1-diabetes-glitter-study-2-10912https://curecurrent.com/trials/feasibility-of-automated-insulin-delivery-with-an-interoperable-algorithm-using-an-alternative-insulin-pump-10913https://curecurrent.com/trials/diabetes-metabolic-syndrome-and-risk-of-malaria-in-cameroon-10914https://curecurrent.com/trials/comparison-of-active-vs-passive-neural-mobilizations-effects-in-improving-burning-pain-muscular-strength-and-range-of-mo-10915https://curecurrent.com/trials/a-study-of-gm-xantho-in-pressure-ulcer-patients-10916https://curecurrent.com/trials/premature-aging-and-type-2-diabetes-mellitus-an-increased-risk-of-cardiomyopathy-10917https://curecurrent.com/trials/pancreatic-islet-transplantation-to-the-anterior-chamber-of-the-eye-10918https://curecurrent.com/trials/genetic-determinants-of-kidney-disease-in-people-of-african-ancestry-with-hiv-10919https://curecurrent.com/trials/development-and-validation-of-a-comprehensive-management-service-package-for-older-adults-with-multimorbidity-10920https://curecurrent.com/trials/immune-cells-in-diabetic-chronic-foot-ulcers-10921https://curecurrent.com/trials/digital-individualized-and-collaborative-treatment-of-t2d-in-general-practice-based-on-decision-aid-10922https://curecurrent.com/trials/feasibility-of-individualized-dietary-plan-idp-on-glycemic-control-and-total-cholestrol-in-diabetic-patients-at-diabetes-10923https://curecurrent.com/trials/efficacy-and-safety-of-an-artificial-intelligence-tool-for-carbohydrate-counting-tiabete-in-children-and-adults-with-typ-10924https://curecurrent.com/trials/registry-study-to-determine-the-effectiveness-and-safety-of-weight-loss-with-enavogliflozin-in-patients-with-type-2-diab-10925https://curecurrent.com/trials/engagement-of-community-through-participatory-learning-and-action-for-control-and-prevention-of-type-ii-diabetes-and-its-10926https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-envlo-tablet-or-envlomet-sr-tablet-in-patients-with-type-ii-diabetes-mellitus-10927https://curecurrent.com/trials/effect-of-linking-data-using-smartphone-application-well-check-on-clinical-outcomes-in-patients-with-type-2-diabetes-mel-10928https://curecurrent.com/trials/effects-of-enavogliflozin-on-coronary-microvascular-and-cardiac-function-in-obesity-10929https://curecurrent.com/trials/glucagon-and-advanced-hcl-system-to-prevent-exercise-induced-hypoglycaemia-in-people-with-type-1-diabetes-10930https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-of-fermented-deglycyrrhizinated-licorice-extract-10931https://curecurrent.com/trials/can-the-addition-of-pioglitazone-to-sglt2-inhibitor-in-type-1-diabetic-patients-amplify-the-decrease-in-hba1c-and-preven-10932https://curecurrent.com/trials/anti-thrombotic-and-glucose-lowering-therapy-in-diabetic-patients-undergoing-pci-10933https://curecurrent.com/trials/effectiveness-of-diabetes-self-management-education-on-glycaemic-control-in-patients-with-t2dm-10934https://curecurrent.com/trials/oral-nutritional-supplement-in-type-2-diabetes-subjects-with-or-at-risk-of-malnutrition-10935https://curecurrent.com/trials/comparison-study-of-insulin-gzr4-with-insulin-degludec-10936https://curecurrent.com/trials/microangiopathy-in-diabetes-10937https://curecurrent.com/trials/fat-around-heart-arteries-as-a-measure-of-inflammation-in-patients-with-glycometabolic-disease-10938https://curecurrent.com/trials/esgliteo-post-marketing-surveillance-pms-in-korean-patients-with-type-2-diabetes-mellitus-10939https://curecurrent.com/trials/the-mommii-study-diabetes-prevention-intervention-on-families-with-past-gestational-diabetes-10940https://curecurrent.com/trials/stigma-and-its-impact-on-glucose-control-among-youth-with-diabetes-a-canada-wide-study-10941https://curecurrent.com/trials/active-patient-gdm-10942https://curecurrent.com/trials/development-of-a-fast-measurement-technique-of-insulin-resistance-in-human-10943https://curecurrent.com/trials/step-monitoring-to-improve-arterial-health-10944https://curecurrent.com/trials/mesenchymal-stromal-stem-cells-derived-exosomes-msc-exos-therapy-for-type-2-diabetes-mellitus-patients-10945https://curecurrent.com/trials/feasibility-study-of-a-behavioral-parent-intervention-to-support-self-management-in-pediatric-typ-1-diabetes-10946https://curecurrent.com/trials/changes-in-the-dietary-patterns-of-adults-in-care-of-a-newly-diagnosed-type-1-diabetes-mellitus-child-10947https://curecurrent.com/trials/a-personalized-self-care-support-program-for-primary-care-patients-with-diabetic-foot-ulcer-10948https://curecurrent.com/trials/indonesian-language-application-based-guided-imagery-therapy-for-insomnia-and-glycemic-control-in-diabetic-patients-10949https://curecurrent.com/trials/regenerative-injection-of-stem-cells-or-stem-cell-derived-exosomes-for-erectile-dysfunction-rise-10950https://curecurrent.com/trials/a-study-on-the-safety-preliminary-efficacy-and-cellular-kinetics-of-allo-cd7-car-t-cells-in-t1dm-10951https://curecurrent.com/trials/mindfulness-informed-intervention-for-improving-diabetes-outcomes-in-type-2-diabetes-10952https://curecurrent.com/trials/whole-body-vibration-therapy-in-individuals-with-type-2-diabetes-10953https://curecurrent.com/trials/a-study-of-ray1225-in-participants-with-type-2-diabetes-not-controlled-with-diet-and-exercise-alone-10954https://curecurrent.com/trials/a-study-of-ray1225-versus-semaglutide-as-add-on-therapy-to-oral-antidiabetic-drugs-in-participants-with-type-2-diabetes-10955https://curecurrent.com/trials/a-research-study-to-evaluate-blx-7006-in-healthy-adults-10956https://curecurrent.com/trials/risk-factor-analysis-for-charcot-foot-in-patients-with-diabetes-mellitus-the-interplay-of-inflammatory-cytokines-and-met-10957https://curecurrent.com/trials/glucose-metabolism-and-live-birth-outcomes-in-pcos-10958https://curecurrent.com/trials/high-dose-vitamin-d3-for-diabetic-foot-ulcer-healing-randomized-controlled-trial-10959https://curecurrent.com/trials/bioequivalence-assessment-between-two-imeglimin-hydrochloride-film-coated-tablet-formulations-10960https://curecurrent.com/trials/the-potential-of-optical-coherence-tomography-angiography-octa-to-detect-early-cognitive-dysfunction-in-diabetic-patient-10961https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-e-islet-01-in-participants-with-type-1-diabetes-10962https://curecurrent.com/trials/periodontitis-severity-in-patients-with-diabetic-retinopathy-10963https://curecurrent.com/trials/triglyceride-rich-lipoproteins-and-platelet-activation-in-type-2-diabetes-10964https://curecurrent.com/trials/my-eyes-my-light-amar-chokh-amar-alo-10965https://curecurrent.com/trials/post-market-clinical-follow-up-of-the-ct3-series-continuous-glucose-monitoring-system-a-14-day-observational-study-asses-10966https://curecurrent.com/trials/a-double-blind-randomized-placebo-controlled-phase-iia-clinical-trial-to-evaluate-the-safety-and-efficacy-of-dt2-sct-in-10967https://curecurrent.com/trials/health-in-mobile-for-community-dwelling-individuals-with-chronic-diseases-10968https://curecurrent.com/trials/the-biosensor-using-the-target-urine-vocs-for-detecting-dkd-diabetic-kidney-disease-10969https://curecurrent.com/trials/acupuncture-for-prediabetes-with-combined-obesity-10970https://curecurrent.com/trials/comparison-of-progressive-muscle-relaxation-and-stretching-exercises-in-diabetic-population-10971https://curecurrent.com/trials/curcumin-s-effect-on-diabetic-patients-with-atherosclerotic-cardiovascular-risk-10972https://curecurrent.com/trials/ai-assisted-comprehensive-management-for-cancer-patients-with-comorbidities-gcog-cg001-10973https://curecurrent.com/trials/gestational-diabetes-after-gastric-bypass-surgery-10974https://curecurrent.com/trials/parodontitis-and-type-2-diabetes-in-elderly-subjects-10975https://curecurrent.com/trials/accuracy-of-interstitial-continuous-glucose-sensors-in-neonates-10976https://curecurrent.com/trials/evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-rz-629-in-healthy-subjects-and-t2d-10977https://curecurrent.com/trials/how-abnormal-function-of-fat-tissue-in-type-1-diabetes-contributes-to-fat-in-the-liver-10978https://curecurrent.com/trials/carbohydrate-loading-and-diabetes-in-colorectal-surgery-10979https://curecurrent.com/trials/effect-of-tai-chi-versus-moderate-intensity-combined-exercise-training-on-cardiovascular-health-and-physical-functional-10980https://curecurrent.com/trials/a-single-arm-multicenter-exploratory-clinical-study-of-tace-combined-with-iparomlimab-and-tuvonralimab-injection-ql1706-10981https://curecurrent.com/trials/efficacy-of-hyaluronic-acid-cream-in-preventing-foot-ulceration-risk-in-patients-with-type-2-diabetes-and-moderate-to-se-10982https://curecurrent.com/trials/best-practice-study-of-diabetes-type-2-management-in-primary-care-in-switzerland-10983https://curecurrent.com/trials/akkermansia-muciniphilia-and-metabolic-side-effects-of-adt-10984https://curecurrent.com/trials/effects-of-insole-vibration-with-proprioceptive-training-in-patients-with-diabetic-peripheral-neuropathy-10985https://curecurrent.com/trials/a-lifestyle-change-program-for-managing-diabetes-10986https://curecurrent.com/trials/flash-glucose-monitoring-targets-in-gestational-diabetes-10987https://curecurrent.com/trials/towards-precision-medicine-for-diabetes-in-pregnancy-10988https://curecurrent.com/trials/impact-of-antepartum-breast-milk-expression-on-breastfeeding-rates-in-patients-with-gestational-diabetes-mellitus-10989https://curecurrent.com/trials/small-bowel-diversion-10990https://curecurrent.com/trials/need-driven-treatment-of-the-patients-with-type-1-diabetes-10991https://curecurrent.com/trials/impact-of-lll-and-aerobic-exercise-on-peripheral-arterial-outcomes-in-patients-with-type-2-diabetes-10992https://curecurrent.com/trials/cgm-use-in-non-insulin-patients-with-dm2-10993https://curecurrent.com/trials/the-application-of-an-ai-driven-multimodal-predictive-model-for-cognitive-impairment-in-patients-with-type-2-diabetes-me-10994https://curecurrent.com/trials/fdgl-dose-finding-study-for-diabetic-neuropathy-10995https://curecurrent.com/trials/lifestyle-intervention-and-its-effects-on-inflammatory-cytokines-and-oxidative-stress-markers-in-diabetic-chronic-kidney-10996https://curecurrent.com/trials/a-single-arm-multicenter-exploratory-clinical-study-of-transarterial-chemoembolization-tace-combined-with-iparomlimab-an-10997https://curecurrent.com/trials/winter-swimming-and-brown-adipose-tissue-activity-in-middel-aged-obese-subjects-winterbat-10998https://curecurrent.com/trials/evaluate-safety-of-adipose-derived-mesenchymal-stem-cell-transplantation-for-type-1-diabetes-treatment-10999https://curecurrent.com/trials/hybrid-closed-loop-insulin-pump-and-bariatric-surgery-in-patients-with-type-1-diabetes-11000